# pathway_nodes

date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £21,412
first_seen: 2019-12-15
last_seen: 2024-09-13
first_seen_parent: 2019-09-22
last_seen_parent: 2024-04-16
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 245.3, "avg_administrations": 6}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 23 times with a 3.3 weekly interval (75.9 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £13,841
first_seen: 2020-03-13
last_seen: 2025-10-19
first_seen_parent: 2020-04-21
last_seen_parent: 2024-08-02
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 205.6, "avg_administrations": 21}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 15 times with a 2.5 weekly interval (37.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £8,082
first_seen: 2018-04-05
last_seen: 2024-12-17
first_seen_parent: 2018-04-03
last_seen_parent: 2025-05-31
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 405.2, "avg_administrations": 9}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 10 times with a 9.0 weekly interval (90.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £6,101
first_seen: 2022-10-29
last_seen: 2025-09-29
first_seen_parent: 2018-04-14
last_seen_parent: 2024-04-16
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 30 times with a 7.9 weekly interval (237.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 5 times with a 3.0 weekly interval (15.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 252.3, "avg_administrations": 5}, {"drug": "NATALIZUMAB", "avg_dose_mg": 128.9, "avg_administrations": 17}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £5,559
first_seen: 2019-10-28
last_seen: 2025-08-31
first_seen_parent: 2021-11-09
last_seen_parent: 2025-01-13
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 9 times with a 7.3 weekly interval (65.7 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 15 times with a 6.3 weekly interval (94.5 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 411.8, "avg_administrations": 10}, {"drug": "NIVOLUMAB", "avg_dose_mg": 109.6, "avg_administrations": 29}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £4,627
first_seen: 2021-08-11
last_seen: 2025-08-17
first_seen_parent: 2019-03-24
last_seen_parent: 2025-12-19
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 476.6, "avg_administrations": 12}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 11 times with a 7.9 weekly interval (86.9 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £5,393
first_seen: 2021-02-17
last_seen: 2024-02-12
first_seen_parent: 2019-07-25
last_seen_parent: 2024-09-01
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 278.7, "avg_administrations": 29}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 20 times with a 11.0 weekly interval (220.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ADALIMUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £14,860
first_seen: 2019-07-24
last_seen: 2024-11-16
first_seen_parent: 2019-08-30
last_seen_parent: 2025-06-26
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 27 times with a 11.0 weekly interval (297.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 30 times with a 2.5 weekly interval (75.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 192.4, "avg_administrations": 13}, {"drug": "TOFACITINIB", "avg_dose_mg": 472.2, "avg_administrations": 14}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ADALIMUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £7,389
first_seen: 2021-01-11
last_seen: 2024-08-24
first_seen_parent: 2019-07-16
last_seen_parent: 2025-02-25
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7 times with a 9.3 weekly interval (65.1 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 13 times with a 11.4 weekly interval (148.2 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 440.2, "avg_administrations": 10}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 460.5, "avg_administrations": 27}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £12,277
first_seen: 2019-04-16
last_seen: 2025-03-22
first_seen_parent: 2017-02-14
last_seen_parent: 2025-05-16
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 257.8, "avg_administrations": 7}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 30 times with a 6.7 weekly interval (201.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £6,815
first_seen: 2021-10-03
last_seen: 2024-03-16
first_seen_parent: 2017-01-28
last_seen_parent: 2024-05-09
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 152.9, "avg_administrations": 10}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 23 times with a 5.2 weekly interval (119.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £4,943
first_seen: 2018-09-01
last_seen: 2025-06-23
first_seen_parent: 2018-04-03
last_seen_parent: 2025-09-26
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 60.5, "avg_administrations": 20}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 28 times with a 8.9 weekly interval (249.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £17,958
first_seen: 2018-05-21
last_seen: 2024-11-25
first_seen_parent: 2020-03-02
last_seen_parent: 2025-09-09
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 347.6, "avg_administrations": 7}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 15 times with a 10.7 weekly interval (160.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £8,595
first_seen: 2020-03-14
last_seen: 2024-05-29
first_seen_parent: 2020-02-01
last_seen_parent: 2024-07-29
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 254.5, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 15 times with a 9.4 weekly interval (141.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £7,886
first_seen: 2022-03-04
last_seen: 2024-03-24
first_seen_parent: 2018-10-19
last_seen_parent: 2025-03-17
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 16 times with a 11.3 weekly interval (180.8 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 28 times with a 6.2 weekly interval (173.6 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 192.7, "avg_administrations": 18}, {"drug": "RITUXIMAB", "avg_dose_mg": 313.8, "avg_administrations": 30}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £15,789
first_seen: 2019-07-20
last_seen: 2024-08-04
first_seen_parent: 2019-07-19
last_seen_parent: 2024-08-02
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 13 times with a 8.4 weekly interval (109.2 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 13 times with a 11.1 weekly interval (144.3 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 59.2, "avg_administrations": 28}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 419.4, "avg_administrations": 18}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £14,086
first_seen: 2021-04-11
last_seen: 2025-03-03
first_seen_parent: 2020-01-08
last_seen_parent: 2025-10-29
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 380.0, "avg_administrations": 11}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 16 times with a 5.2 weekly interval (83.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £5,277
first_seen: 2020-02-21
last_seen: 2025-12-18
first_seen_parent: 2020-01-22
last_seen_parent: 2024-06-20
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 10 times with a 4.6 weekly interval (46.0 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 7 times with a 3.0 weekly interval (21.0 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 470.8, "avg_administrations": 16}, {"drug": "IBRUTINIB", "avg_dose_mg": 288.2, "avg_administrations": 20}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £20,854
first_seen: 2022-01-03
last_seen: 2025-12-18
first_seen_parent: 2021-12-07
last_seen_parent: 2024-03-12
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 7 times with a 8.2 weekly interval (57.4 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 12 times with a 5.5 weekly interval (66.0 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 81.4, "avg_administrations": 30}, {"drug": "SECUKINUMAB", "avg_dose_mg": 394.1, "avg_administrations": 23}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £12,624
first_seen: 2020-08-30
last_seen: 2024-01-03
first_seen_parent: 2019-10-24
last_seen_parent: 2024-04-15
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 83.7, "avg_administrations": 22}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 29 times with a 9.3 weekly interval (269.7 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £11,472
first_seen: 2020-02-14
last_seen: 2025-05-06
first_seen_parent: 2018-03-10
last_seen_parent: 2024-11-08
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 27 times with a 4.5 weekly interval (121.5 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 10 times with a 11.3 weekly interval (113.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 439.3, "avg_administrations": 27}, {"drug": "INFLIXIMAB", "avg_dose_mg": 390.4, "avg_administrations": 27}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £5,794
first_seen: 2020-01-08
last_seen: 2024-03-09
first_seen_parent: 2021-09-14
last_seen_parent: 2025-01-20
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 6 times with a 6.2 weekly interval (37.2 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 11 times with a 7.6 weekly interval (83.6 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 244.4, "avg_administrations": 19}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 313.7, "avg_administrations": 15}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £6,773
first_seen: 2019-03-28
last_seen: 2024-08-14
first_seen_parent: 2019-11-13
last_seen_parent: 2024-08-16
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 476.9, "avg_administrations": 26}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 22 times with a 7.2 weekly interval (158.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - IBRUTINIB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £17,409
first_seen: 2021-04-12
last_seen: 2024-07-12
first_seen_parent: 2021-04-05
last_seen_parent: 2024-12-18
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 29 times with a 9.1 weekly interval (263.9 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 13 times with a 4.3 weekly interval (55.9 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 264.7, "avg_administrations": 10}, {"drug": "NATALIZUMAB", "avg_dose_mg": 322.4, "avg_administrations": 30}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - IBRUTINIB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £14,510
first_seen: 2021-11-24
last_seen: 2025-08-21
first_seen_parent: 2021-07-03
last_seen_parent: 2024-02-08
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 13 times with a 6.8 weekly interval (88.4 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 24 times with a 8.3 weekly interval (199.2 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 209.0, "avg_administrations": 27}, {"drug": "TOFACITINIB", "avg_dose_mg": 453.3, "avg_administrations": 25}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £22,553
first_seen: 2020-04-01
last_seen: 2024-12-31
first_seen_parent: 2018-10-06
last_seen_parent: 2025-12-26
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 218.2, "avg_administrations": 11}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 23 times with a 4.3 weekly interval (98.9 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £21,281
first_seen: 2019-05-26
last_seen: 2024-06-02
first_seen_parent: 2019-08-09
last_seen_parent: 2025-12-18
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 10 times with a 4.5 weekly interval (45.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 17 times with a 5.4 weekly interval (91.8 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 451.6, "avg_administrations": 21}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 130.0, "avg_administrations": 26}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £14,153
first_seen: 2018-11-11
last_seen: 2024-11-11
first_seen_parent: 2017-11-25
last_seen_parent: 2025-01-16
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 348.1, "avg_administrations": 12}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 4 times with a 7.8 weekly interval (31.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £9,772
first_seen: 2019-08-11
last_seen: 2025-09-17
first_seen_parent: 2018-10-07
last_seen_parent: 2025-01-25
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 471.6, "avg_administrations": 12}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 16 times with a 4.1 weekly interval (65.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £3,501
first_seen: 2020-06-24
last_seen: 2025-03-28
first_seen_parent: 2019-05-25
last_seen_parent: 2024-07-29
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 414.2, "avg_administrations": 24}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 11 times with a 10.7 weekly interval (117.7 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £12,286
first_seen: 2021-10-10
last_seen: 2024-06-04
first_seen_parent: 2020-01-24
last_seen_parent: 2025-05-07
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 402.0, "avg_administrations": 11}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 27 times with a 10.4 weekly interval (280.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £24,622
first_seen: 2019-03-31
last_seen: 2025-03-01
first_seen_parent: 2017-07-02
last_seen_parent: 2024-06-24
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 312.0, "avg_administrations": 5}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 26 times with a 2.9 weekly interval (75.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £22,681
first_seen: 2020-12-19
last_seen: 2024-05-28
first_seen_parent: 2017-02-25
last_seen_parent: 2025-03-14
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 167.4, "avg_administrations": 9}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 22 times with a 10.6 weekly interval (233.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £8,648
first_seen: 2019-01-12
last_seen: 2025-08-20
first_seen_parent: 2021-02-03
last_seen_parent: 2024-10-28
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 11 times with a 9.9 weekly interval (108.9 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 28 times with a 5.0 weekly interval (140.0 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 306.5, "avg_administrations": 27}, {"drug": "USTEKINUMAB", "avg_dose_mg": 382.8, "avg_administrations": 24}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £7,172
first_seen: 2022-10-01
last_seen: 2024-03-21
first_seen_parent: 2018-12-28
last_seen_parent: 2024-03-25
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 29 times with a 6.6 weekly interval (191.4 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 29 times with a 8.2 weekly interval (237.8 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 479.7, "avg_administrations": 24}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 105.9, "avg_administrations": 28}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £21,387
first_seen: 2021-12-25
last_seen: 2024-04-22
first_seen_parent: 2020-12-07
last_seen_parent: 2024-09-30
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 490.6, "avg_administrations": 16}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 16 times with a 5.8 weekly interval (92.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £6,322
first_seen: 2020-04-09
last_seen: 2024-05-28
first_seen_parent: 2020-02-18
last_seen_parent: 2024-02-15
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 131.7, "avg_administrations": 16}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 14 times with a 8.1 weekly interval (113.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £17,252
first_seen: 2020-10-03
last_seen: 2024-02-12
first_seen_parent: 2018-07-12
last_seen_parent: 2025-12-17
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 313.2, "avg_administrations": 28}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 23 times with a 11.4 weekly interval (262.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £23,877
first_seen: 2020-09-10
last_seen: 2024-09-27
first_seen_parent: 2020-01-24
last_seen_parent: 2025-02-04
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 344.4, "avg_administrations": 21}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 11 times with a 7.2 weekly interval (79.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £24,263
first_seen: 2021-06-13
last_seen: 2025-01-16
first_seen_parent: 2020-03-27
last_seen_parent: 2025-07-24
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 345.2, "avg_administrations": 8}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 7 times with a 6.1 weekly interval (42.7 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - RITUXIMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £9,815
first_seen: 2019-12-27
last_seen: 2024-08-09
first_seen_parent: 2018-05-28
last_seen_parent: 2025-02-01
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 16 times with a 8.1 weekly interval (129.6 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 29 times with a 8.3 weekly interval (240.7 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 424.9, "avg_administrations": 30}, {"drug": "SECUKINUMAB", "avg_dose_mg": 54.9, "avg_administrations": 21}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £15,386
first_seen: 2019-01-17
last_seen: 2024-04-10
first_seen_parent: 2020-07-29
last_seen_parent: 2024-08-05
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 482.1, "avg_administrations": 20}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 20 times with a 3.5 weekly interval (70.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £21,141
first_seen: 2018-12-18
last_seen: 2025-11-14
first_seen_parent: 2020-01-18
last_seen_parent: 2024-02-12
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 175.0, "avg_administrations": 13}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 4 times with a 3.4 weekly interval (13.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - SECUKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - SECUKINUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £3,519
first_seen: 2019-09-20
last_seen: 2024-02-01
first_seen_parent: 2020-05-13
last_seen_parent: 2025-06-10
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 6 times with a 10.5 weekly interval (63.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 19 times with a 4.5 weekly interval (85.5 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 329.8, "avg_administrations": 13}, {"drug": "ADALIMUMAB", "avg_dose_mg": 242.2, "avg_administrations": 28}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £11,216
first_seen: 2019-01-10
last_seen: 2025-12-19
first_seen_parent: 2017-07-02
last_seen_parent: 2024-11-11
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 414.4, "avg_administrations": 18}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 14 times with a 3.6 weekly interval (50.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - TOFACITINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - TOFACITINIB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £13,668
first_seen: 2020-12-26
last_seen: 2025-04-17
first_seen_parent: 2021-10-21
last_seen_parent: 2025-03-24
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 10 times with a 9.4 weekly interval (94.0 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 4 times with a 5.7 weekly interval (22.8 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 381.0, "avg_administrations": 28}, {"drug": "IBRUTINIB", "avg_dose_mg": 236.5, "avg_administrations": 13}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £19,293
first_seen: 2020-04-01
last_seen: 2024-06-23
first_seen_parent: 2018-04-25
last_seen_parent: 2025-02-24
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 358.5, "avg_administrations": 30}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 22 times with a 7.1 weekly interval (156.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - INFLIXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - INFLIXIMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £10,959
first_seen: 2020-04-08
last_seen: 2025-06-05
first_seen_parent: 2021-12-07
last_seen_parent: 2024-04-16
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 27 times with a 11.5 weekly interval (310.5 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 28 times with a 5.1 weekly interval (142.8 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 224.7, "avg_administrations": 15}, {"drug": "ETANERCEPT", "avg_dose_mg": 71.0, "avg_administrations": 21}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - INFLIXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - INFLIXIMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £15,823
first_seen: 2019-09-25
last_seen: 2024-01-09
first_seen_parent: 2020-10-18
last_seen_parent: 2024-06-07
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 22 times with a 7.9 weekly interval (173.8 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 28 times with a 2.9 weekly interval (81.2 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 256.4, "avg_administrations": 4}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 351.2, "avg_administrations": 15}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £13,832
first_seen: 2018-12-28
last_seen: 2024-05-02
first_seen_parent: 2018-04-25
last_seen_parent: 2024-07-06
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 438.4, "avg_administrations": 11}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 9 times with a 10.5 weekly interval (94.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £25,472
first_seen: 2019-03-27
last_seen: 2025-03-13
first_seen_parent: 2018-10-19
last_seen_parent: 2024-04-08
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 266.4, "avg_administrations": 25}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 15 times with a 8.9 weekly interval (133.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £22,135
first_seen: 2021-01-25
last_seen: 2024-09-23
first_seen_parent: 2019-08-10
last_seen_parent: 2024-07-31
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 305.3, "avg_administrations": 13}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 28 times with a 3.8 weekly interval (106.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £22,442
first_seen: 2020-06-15
last_seen: 2025-01-26
first_seen_parent: 2020-10-22
last_seen_parent: 2025-11-12
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 144.5, "avg_administrations": 13}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 27 times with a 4.9 weekly interval (132.3 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £9,171
first_seen: 2020-09-30
last_seen: 2024-08-30
first_seen_parent: 2017-12-10
last_seen_parent: 2025-01-22
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 136.5, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 19 times with a 9.1 weekly interval (172.9 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - OCRELIZUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £19,045
first_seen: 2020-03-26
last_seen: 2024-10-08
first_seen_parent: 2020-09-19
last_seen_parent: 2025-09-12
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 16 times with a 2.1 weekly interval (33.6 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 26 times with a 4.2 weekly interval (109.2 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 164.4, "avg_administrations": 15}, {"drug": "NIVOLUMAB", "avg_dose_mg": 187.5, "avg_administrations": 15}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - OCRELIZUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £4,123
first_seen: 2019-04-19
last_seen: 2025-07-10
first_seen_parent: 2020-06-15
last_seen_parent: 2024-02-13
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 10 times with a 6.3 weekly interval (63.0 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 22 times with a 11.2 weekly interval (246.4 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 267.7, "avg_administrations": 15}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 140.1, "avg_administrations": 15}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £15,309
first_seen: 2021-09-07
last_seen: 2025-04-16
first_seen_parent: 2018-03-26
last_seen_parent: 2025-01-18
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 56.3, "avg_administrations": 13}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 11 times with a 12.0 weekly interval (132.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £6,382
first_seen: 2019-09-29
last_seen: 2025-03-11
first_seen_parent: 2020-11-29
last_seen_parent: 2025-02-01
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 238.1, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 8 times with a 5.1 weekly interval (40.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £16,695
first_seen: 2018-05-09
last_seen: 2025-03-13
first_seen_parent: 2020-08-14
last_seen_parent: 2024-03-14
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 195.4, "avg_administrations": 7}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 7 times with a 9.9 weekly interval (69.3 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £18,213
first_seen: 2018-04-28
last_seen: 2024-10-02
first_seen_parent: 2017-08-13
last_seen_parent: 2025-03-06
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 469.3, "avg_administrations": 9}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 19 times with a 9.1 weekly interval (172.9 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £6,999
first_seen: 2020-04-16
last_seen: 2024-03-19
first_seen_parent: 2020-01-28
last_seen_parent: 2024-10-16
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 415.7, "avg_administrations": 28}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 9 times with a 4.7 weekly interval (42.3 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £10,334
first_seen: 2019-09-24
last_seen: 2025-07-05
first_seen_parent: 2019-04-14
last_seen_parent: 2024-11-08
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 333.7, "avg_administrations": 19}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 26 times with a 7.3 weekly interval (189.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £18,269
first_seen: 2020-07-27
last_seen: 2025-07-20
first_seen_parent: 2018-10-11
last_seen_parent: 2024-08-04
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 253.3, "avg_administrations": 14}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 21 times with a 8.6 weekly interval (180.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £13,945
first_seen: 2020-02-03
last_seen: 2025-03-08
first_seen_parent: 2018-08-25
last_seen_parent: 2025-06-14
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 261.0, "avg_administrations": 10}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 28 times with a 11.2 weekly interval (313.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - RANIBIZUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £14,643
first_seen: 2020-12-28
last_seen: 2024-11-21
first_seen_parent: 2019-01-22
last_seen_parent: 2024-01-25
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 12 times with a 2.2 weekly interval (26.4 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 26 times with a 4.1 weekly interval (106.6 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 406.7, "avg_administrations": 8}, {"drug": "ADALIMUMAB", "avg_dose_mg": 186.6, "avg_administrations": 24}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £7,445
first_seen: 2020-10-02
last_seen: 2025-01-06
first_seen_parent: 2017-09-16
last_seen_parent: 2024-11-01
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 130.5, "avg_administrations": 30}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 26 times with a 2.1 weekly interval (54.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £21,402
first_seen: 2021-05-11
last_seen: 2025-01-23
first_seen_parent: 2020-11-12
last_seen_parent: 2024-08-18
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 443.7, "avg_administrations": 22}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11 times with a 9.2 weekly interval (101.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £4,088
first_seen: 2020-06-20
last_seen: 2025-04-29
first_seen_parent: 2019-05-05
last_seen_parent: 2025-06-03
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 390.2, "avg_administrations": 13}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 29 times with a 11.0 weekly interval (319.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - SECUKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - SECUKINUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £11,086
first_seen: 2019-08-02
last_seen: 2024-09-15
first_seen_parent: 2018-08-05
last_seen_parent: 2024-10-07
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 12 times with a 8.6 weekly interval (103.2 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 24 times with a 7.1 weekly interval (170.4 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 189.0, "avg_administrations": 20}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 207.0, "avg_administrations": 19}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - SECUKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - SECUKINUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £13,201
first_seen: 2020-10-06
last_seen: 2024-10-18
first_seen_parent: 2018-08-07
last_seen_parent: 2025-06-15
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 17 times with a 5.2 weekly interval (88.4 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 26 times with a 10.1 weekly interval (262.6 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 473.9, "avg_administrations": 18}, {"drug": "ADALIMUMAB", "avg_dose_mg": 198.8, "avg_administrations": 29}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £6,109
first_seen: 2018-10-13
last_seen: 2024-09-13
first_seen_parent: 2018-04-13
last_seen_parent: 2025-11-04
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 373.9, "avg_administrations": 27}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 25 times with a 9.8 weekly interval (245.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - USTEKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - USTEKINUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £5,472
first_seen: 2019-04-25
last_seen: 2024-09-17
first_seen_parent: 2020-10-30
last_seen_parent: 2024-10-22
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 9 times with a 4.4 weekly interval (39.6 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 23 times with a 11.9 weekly interval (273.7 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 331.0, "avg_administrations": 19}, {"drug": "RITUXIMAB", "avg_dose_mg": 445.8, "avg_administrations": 26}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £9,934
first_seen: 2021-07-03
last_seen: 2024-07-10
first_seen_parent: 2019-04-14
last_seen_parent: 2025-11-21
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 228.4, "avg_administrations": 8}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 16 times with a 7.5 weekly interval (120.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - BARICITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - BARICITINIB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £10,938
first_seen: 2022-06-19
last_seen: 2024-01-01
first_seen_parent: 2021-04-27
last_seen_parent: 2025-10-10
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: BARICITINIB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 29 times with a 9.8 weekly interval (284.2 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 23 times with a 7.2 weekly interval (165.6 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 108.1, "avg_administrations": 20}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 85.2, "avg_administrations": 24}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - BARICITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - BARICITINIB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £11,202
first_seen: 2022-01-29
last_seen: 2025-04-11
first_seen_parent: 2018-11-20
last_seen_parent: 2024-08-05
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: BARICITINIB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 21 times with a 6.0 weekly interval (126.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 14 times with a 9.8 weekly interval (137.2 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 147.9, "avg_administrations": 6}, {"drug": "ADALIMUMAB", "avg_dose_mg": 437.5, "avg_administrations": 16}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £17,239
first_seen: 2021-12-24
last_seen: 2025-10-17
first_seen_parent: 2017-12-27
last_seen_parent: 2024-10-14
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 235.8, "avg_administrations": 14}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 23 times with a 9.8 weekly interval (225.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ETANERCEPT
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ETANERCEPT - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £9,663
first_seen: 2019-01-16
last_seen: 2025-12-16
first_seen_parent: 2019-03-26
last_seen_parent: 2025-11-10
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 11 times with a 2.9 weekly interval (31.9 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 9 times with a 11.8 weekly interval (106.2 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 160.0, "avg_administrations": 10}, {"drug": "NATALIZUMAB", "avg_dose_mg": 73.5, "avg_administrations": 26}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ETANERCEPT
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ETANERCEPT - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £8,583
first_seen: 2021-01-19
last_seen: 2024-11-21
first_seen_parent: 2020-07-07
last_seen_parent: 2024-08-30
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 20 times with a 9.5 weekly interval (190.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 14 times with a 10.9 weekly interval (152.6 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 185.4, "avg_administrations": 23}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 382.7, "avg_administrations": 9}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £18,408
first_seen: 2018-10-01
last_seen: 2025-01-20
first_seen_parent: 2020-10-14
last_seen_parent: 2024-05-03
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 428.5, "avg_administrations": 25}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 26 times with a 10.0 weekly interval (260.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £16,369
first_seen: 2018-07-03
last_seen: 2024-07-09
first_seen_parent: 2017-07-05
last_seen_parent: 2025-05-03
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 79.9, "avg_administrations": 4}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 24 times with a 4.3 weekly interval (103.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £21,008
first_seen: 2020-03-05
last_seen: 2024-05-04
first_seen_parent: 2019-11-18
last_seen_parent: 2024-09-03
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 113.0, "avg_administrations": 24}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 9 times with a 6.3 weekly interval (56.7 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £7,099
first_seen: 2021-01-28
last_seen: 2024-11-15
first_seen_parent: 2017-07-08
last_seen_parent: 2024-07-06
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 98.5, "avg_administrations": 14}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 28 times with a 11.2 weekly interval (313.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £9,270
first_seen: 2022-11-23
last_seen: 2025-10-12
first_seen_parent: 2021-08-03
last_seen_parent: 2024-07-13
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 13 times with a 3.9 weekly interval (50.7 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 16 times with a 11.0 weekly interval (176.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 418.7, "avg_administrations": 8}, {"drug": "RITUXIMAB", "avg_dose_mg": 282.2, "avg_administrations": 6}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £14,744
first_seen: 2019-10-30
last_seen: 2025-11-29
first_seen_parent: 2018-04-03
last_seen_parent: 2025-02-18
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 220.9, "avg_administrations": 14}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9 times with a 9.7 weekly interval (87.3 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £5,995
first_seen: 2022-06-25
last_seen: 2024-01-15
first_seen_parent: 2020-09-01
last_seen_parent: 2025-10-16
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 7 times with a 10.9 weekly interval (76.3 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 21 times with a 3.1 weekly interval (65.1 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 398.5, "avg_administrations": 27}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 382.5, "avg_administrations": 22}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £9,949
first_seen: 2019-08-07
last_seen: 2024-09-09
first_seen_parent: 2017-11-28
last_seen_parent: 2025-08-21
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 438.0, "avg_administrations": 19}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 26 times with a 11.8 weekly interval (306.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - RITUXIMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £9,255
first_seen: 2022-12-15
last_seen: 2025-06-14
first_seen_parent: 2020-06-04
last_seen_parent: 2025-04-19
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 12 times with a 11.3 weekly interval (135.6 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 18 times with a 7.3 weekly interval (131.4 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 229.3, "avg_administrations": 16}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 153.8, "avg_administrations": 21}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - RITUXIMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £5,525
first_seen: 2020-06-20
last_seen: 2024-09-12
first_seen_parent: 2020-10-07
last_seen_parent: 2025-03-19
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7 times with a 10.3 weekly interval (72.1 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 27 times with a 2.1 weekly interval (56.7 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 401.5, "avg_administrations": 13}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 363.2, "avg_administrations": 30}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £9,204
first_seen: 2021-12-20
last_seen: 2024-03-30
first_seen_parent: 2020-09-14
last_seen_parent: 2024-01-06
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 111.0, "avg_administrations": 20}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 24 times with a 9.0 weekly interval (216.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £9,038
first_seen: 2021-06-03
last_seen: 2025-12-06
first_seen_parent: 2021-10-27
last_seen_parent: 2025-03-01
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 18 times with a 3.4 weekly interval (61.2 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 6 times with a 8.6 weekly interval (51.6 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 125.1, "avg_administrations": 6}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 169.3, "avg_administrations": 22}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £23,604
first_seen: 2020-12-11
last_seen: 2024-02-10
first_seen_parent: 2021-07-13
last_seen_parent: 2025-05-06
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 20 times with a 9.2 weekly interval (184.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 12 times with a 2.3 weekly interval (27.6 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 303.5, "avg_administrations": 12}, {"drug": "ETANERCEPT", "avg_dose_mg": 313.4, "avg_administrations": 25}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £18,241
first_seen: 2019-02-21
last_seen: 2025-08-13
first_seen_parent: 2019-03-27
last_seen_parent: 2024-01-04
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 404.4, "avg_administrations": 17}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 16 times with a 6.6 weekly interval (105.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £4,785
first_seen: 2020-12-11
last_seen: 2024-07-24
first_seen_parent: 2019-11-11
last_seen_parent: 2024-06-18
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 18 times with a 6.3 weekly interval (113.4 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 6 times with a 10.0 weekly interval (60.0 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 428.2, "avg_administrations": 10}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 158.4, "avg_administrations": 26}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £7,548
first_seen: 2021-08-04
last_seen: 2025-10-15
first_seen_parent: 2018-07-11
last_seen_parent: 2025-04-17
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 250.7, "avg_administrations": 21}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 21 times with a 6.9 weekly interval (144.9 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - OCRELIZUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £4,950
first_seen: 2022-05-02
last_seen: 2025-06-14
first_seen_parent: 2018-08-07
last_seen_parent: 2024-04-06
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 16 times with a 4.2 weekly interval (67.2 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 7 times with a 9.4 weekly interval (65.8 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 485.6, "avg_administrations": 29}, {"drug": "IBRUTINIB", "avg_dose_mg": 493.2, "avg_administrations": 28}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £8,849
first_seen: 2020-01-18
last_seen: 2025-09-15
first_seen_parent: 2018-01-21
last_seen_parent: 2025-01-16
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 319.3, "avg_administrations": 8}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 20 times with a 8.5 weekly interval (170.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - NATALIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £8,822
first_seen: 2021-02-06
last_seen: 2025-07-07
first_seen_parent: 2019-06-07
last_seen_parent: 2025-01-06
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 5 times with a 10.0 weekly interval (50.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 12 times with a 8.5 weekly interval (102.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 278.9, "avg_administrations": 9}, {"drug": "TOFACITINIB", "avg_dose_mg": 92.7, "avg_administrations": 4}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £19,316
first_seen: 2020-09-05
last_seen: 2025-05-22
first_seen_parent: 2018-03-25
last_seen_parent: 2025-10-19
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 359.6, "avg_administrations": 30}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 18 times with a 2.3 weekly interval (41.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - TRASTUZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - TRASTUZUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £8,892
first_seen: 2020-08-07
last_seen: 2025-09-27
first_seen_parent: 2020-03-13
last_seen_parent: 2025-12-18
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 15 times with a 7.5 weekly interval (112.5 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 22 times with a 6.7 weekly interval (147.4 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 481.0, "avg_administrations": 18}, {"drug": "BARICITINIB", "avg_dose_mg": 433.4, "avg_administrations": 11}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £21,207
first_seen: 2021-01-18
last_seen: 2024-12-23
first_seen_parent: 2019-07-29
last_seen_parent: 2025-03-30
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 149.7, "avg_administrations": 28}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 20 times with a 3.3 weekly interval (66.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £12,941
first_seen: 2020-12-11
last_seen: 2024-08-09
first_seen_parent: 2017-09-03
last_seen_parent: 2025-10-04
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 447.6, "avg_administrations": 20}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 22 times with a 10.8 weekly interval (237.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £17,479
first_seen: 2022-01-20
last_seen: 2024-03-25
first_seen_parent: 2019-06-28
last_seen_parent: 2024-07-03
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7 times with a 4.4 weekly interval (30.8 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 20 times with a 8.5 weekly interval (170.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 200.1, "avg_administrations": 7}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 200.7, "avg_administrations": 5}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £3,633
first_seen: 2021-12-29
last_seen: 2024-06-15
first_seen_parent: 2018-01-01
last_seen_parent: 2025-08-31
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 13 times with a 7.9 weekly interval (102.7 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 16 times with a 7.6 weekly interval (121.6 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 349.8, "avg_administrations": 17}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 282.4, "avg_administrations": 12}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £18,197
first_seen: 2021-07-12
last_seen: 2025-10-01
first_seen_parent: 2018-05-25
last_seen_parent: 2024-11-27
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 204.2, "avg_administrations": 7}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6 times with a 7.5 weekly interval (45.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £14,521
first_seen: 2018-10-06
last_seen: 2025-03-03
first_seen_parent: 2019-12-18
last_seen_parent: 2024-03-07
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 333.4, "avg_administrations": 9}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 24 times with a 2.9 weekly interval (69.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £16,352
first_seen: 2021-08-24
last_seen: 2024-07-21
first_seen_parent: 2017-05-01
last_seen_parent: 2024-07-19
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 470.2, "avg_administrations": 28}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 19 times with a 10.1 weekly interval (191.9 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - RITUXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - RITUXIMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £12,456
first_seen: 2021-05-07
last_seen: 2025-03-24
first_seen_parent: 2019-03-12
last_seen_parent: 2025-06-23
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7 times with a 8.1 weekly interval (56.7 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 14 times with a 7.3 weekly interval (102.2 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 480.4, "avg_administrations": 26}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 295.1, "avg_administrations": 17}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - RITUXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - RITUXIMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £11,231
first_seen: 2019-04-15
last_seen: 2025-10-27
first_seen_parent: 2021-04-12
last_seen_parent: 2025-06-16
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 20 times with a 5.5 weekly interval (110.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 26 times with a 3.2 weekly interval (83.2 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 492.5, "avg_administrations": 7}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 325.7, "avg_administrations": 21}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £16,281
first_seen: 2018-09-17
last_seen: 2024-01-22
first_seen_parent: 2018-01-13
last_seen_parent: 2025-08-30
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 193.4, "avg_administrations": 22}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 15 times with a 11.5 weekly interval (172.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £7,124
first_seen: 2018-03-16
last_seen: 2025-08-31
first_seen_parent: 2018-02-01
last_seen_parent: 2025-09-28
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 277.2, "avg_administrations": 29}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 9 times with a 10.9 weekly interval (98.1 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - BARICITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - BARICITINIB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £9,665
first_seen: 2021-10-21
last_seen: 2025-05-06
first_seen_parent: 2018-09-09
last_seen_parent: 2024-03-22
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 15 times with a 10.7 weekly interval (160.5 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 21 times with a 2.4 weekly interval (50.4 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 342.3, "avg_administrations": 28}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 458.2, "avg_administrations": 12}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £3,944
first_seen: 2020-06-20
last_seen: 2024-11-05
first_seen_parent: 2018-05-30
last_seen_parent: 2024-05-01
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 377.4, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 20 times with a 7.7 weekly interval (154.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £5,634
first_seen: 2020-10-22
last_seen: 2024-10-21
first_seen_parent: 2017-02-13
last_seen_parent: 2024-11-30
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 219.5, "avg_administrations": 13}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 19 times with a 6.2 weekly interval (117.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £10,391
first_seen: 2020-08-20
last_seen: 2025-11-14
first_seen_parent: 2017-02-15
last_seen_parent: 2024-09-29
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 350.3, "avg_administrations": 13}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 18 times with a 10.3 weekly interval (185.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - ADALIMUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £4,775
first_seen: 2022-09-27
last_seen: 2024-03-26
first_seen_parent: 2019-01-02
last_seen_parent: 2024-01-22
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 16 times with a 7.2 weekly interval (115.2 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 23 times with a 8.7 weekly interval (200.1 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 263.4, "avg_administrations": 27}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 128.7, "avg_administrations": 13}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £7,079
first_seen: 2020-04-17
last_seen: 2025-05-18
first_seen_parent: 2020-10-19
last_seen_parent: 2024-05-07
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 328.8, "avg_administrations": 13}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 26 times with a 3.7 weekly interval (96.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - TOFACITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - TOFACITINIB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £3,647
first_seen: 2021-09-26
last_seen: 2025-06-13
first_seen_parent: 2019-06-05
last_seen_parent: 2024-09-30
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 4 times with a 5.0 weekly interval (20.0 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 24 times with a 5.9 weekly interval (141.6 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 405.3, "avg_administrations": 12}, {"drug": "BARICITINIB", "avg_dose_mg": 255.5, "avg_administrations": 10}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - TOFACITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - TOFACITINIB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £5,529
first_seen: 2021-12-21
last_seen: 2025-07-10
first_seen_parent: 2018-02-21
last_seen_parent: 2024-09-18
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 23 times with a 11.9 weekly interval (273.7 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 8 times with a 6.0 weekly interval (48.0 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 150.5, "avg_administrations": 8}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 159.4, "avg_administrations": 15}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £8,177
first_seen: 2019-11-15
last_seen: 2025-08-26
first_seen_parent: 2020-08-15
last_seen_parent: 2025-04-07
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 456.8, "avg_administrations": 20}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 20 times with a 9.7 weekly interval (194.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £19,062
first_seen: 2021-04-26
last_seen: 2024-12-21
first_seen_parent: 2018-04-29
last_seen_parent: 2025-05-29
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 157.6, "avg_administrations": 7}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 18 times with a 5.5 weekly interval (99.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £22,583
first_seen: 2020-07-29
last_seen: 2025-05-14
first_seen_parent: 2017-01-30
last_seen_parent: 2025-12-03
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 297.6, "avg_administrations": 11}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 22 times with a 10.8 weekly interval (237.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £19,635
first_seen: 2020-08-12
last_seen: 2024-11-07
first_seen_parent: 2020-10-14
last_seen_parent: 2024-12-28
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 366.2, "avg_administrations": 20}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 5 times with a 9.2 weekly interval (46.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - OCRELIZUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £16,193
first_seen: 2022-10-18
last_seen: 2025-08-08
first_seen_parent: 2019-04-13
last_seen_parent: 2024-06-11
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 24 times with a 10.7 weekly interval (256.8 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 28 times with a 8.2 weekly interval (229.6 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 180.4, "avg_administrations": 6}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 422.4, "avg_administrations": 24}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - OCRELIZUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £15,084
first_seen: 2022-04-19
last_seen: 2024-05-13
first_seen_parent: 2019-08-20
last_seen_parent: 2024-09-15
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 24 times with a 4.0 weekly interval (96.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 14 times with a 4.6 weekly interval (64.4 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 306.8, "avg_administrations": 5}, {"drug": "NIVOLUMAB", "avg_dose_mg": 385.5, "avg_administrations": 27}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £14,880
first_seen: 2019-11-09
last_seen: 2024-06-04
first_seen_parent: 2019-04-26
last_seen_parent: 2025-04-18
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 378.9, "avg_administrations": 17}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 23 times with a 9.6 weekly interval (220.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £13,028
first_seen: 2021-08-03
last_seen: 2024-09-08
first_seen_parent: 2020-01-30
last_seen_parent: 2024-06-18
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 29 times with a 7.0 weekly interval (203.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 20 times with a 10.9 weekly interval (218.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 348.4, "avg_administrations": 17}, {"drug": "SECUKINUMAB", "avg_dose_mg": 280.4, "avg_administrations": 15}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £10,097
first_seen: 2020-11-08
last_seen: 2024-05-13
first_seen_parent: 2019-10-19
last_seen_parent: 2025-03-24
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 19 times with a 6.0 weekly interval (114.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 22 times with a 11.1 weekly interval (244.2 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 341.7, "avg_administrations": 13}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 139.6, "avg_administrations": 21}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £10,400
first_seen: 2019-05-25
last_seen: 2025-09-04
first_seen_parent: 2020-08-14
last_seen_parent: 2025-07-20
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 404.9, "avg_administrations": 26}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 9 times with a 6.3 weekly interval (56.7 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £14,201
first_seen: 2018-06-17
last_seen: 2024-06-16
first_seen_parent: 2020-12-06
last_seen_parent: 2025-11-10
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 278.3, "avg_administrations": 23}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 25 times with a 6.7 weekly interval (167.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - PEMBROLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - PEMBROLIZUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £3,129
first_seen: 2019-08-27
last_seen: 2025-02-08
first_seen_parent: 2021-05-24
last_seen_parent: 2025-04-15
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 12 times with a 3.0 weekly interval (36.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 25 times with a 4.7 weekly interval (117.5 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 411.5, "avg_administrations": 11}, {"drug": "ETANERCEPT", "avg_dose_mg": 61.4, "avg_administrations": 6}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - PEMBROLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - PEMBROLIZUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £22,241
first_seen: 2021-12-27
last_seen: 2024-04-05
first_seen_parent: 2018-03-28
last_seen_parent: 2024-02-05
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 26 times with a 5.3 weekly interval (137.8 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 4 times with a 3.7 weekly interval (14.8 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 246.3, "avg_administrations": 24}, {"drug": "BARICITINIB", "avg_dose_mg": 100.5, "avg_administrations": 30}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £9,774
first_seen: 2019-08-22
last_seen: 2025-07-06
first_seen_parent: 2019-03-12
last_seen_parent: 2024-08-22
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 142.5, "avg_administrations": 12}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 7 times with a 10.3 weekly interval (72.1 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - ADALIMUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - ADALIMUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £15,247
first_seen: 2020-12-20
last_seen: 2025-02-20
first_seen_parent: 2020-10-25
last_seen_parent: 2025-05-13
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5 times with a 5.4 weekly interval (27.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 10 times with a 5.5 weekly interval (55.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 57.5, "avg_administrations": 12}, {"drug": "INFLIXIMAB", "avg_dose_mg": 62.1, "avg_administrations": 7}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £18,422
first_seen: 2020-08-28
last_seen: 2024-09-10
first_seen_parent: 2019-03-11
last_seen_parent: 2024-08-02
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 230.4, "avg_administrations": 5}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7 times with a 5.0 weekly interval (35.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £21,806
first_seen: 2019-11-21
last_seen: 2024-06-11
first_seen_parent: 2020-06-21
last_seen_parent: 2025-12-02
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 80.2, "avg_administrations": 15}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 28 times with a 10.9 weekly interval (305.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £21,076
first_seen: 2018-11-28
last_seen: 2024-07-22
first_seen_parent: 2020-02-22
last_seen_parent: 2025-12-18
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 279.1, "avg_administrations": 17}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 29 times with a 3.8 weekly interval (110.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £18,680
first_seen: 2019-05-16
last_seen: 2025-10-15
first_seen_parent: 2020-10-16
last_seen_parent: 2025-01-12
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 165.9, "avg_administrations": 24}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 27 times with a 8.7 weekly interval (234.9 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ETANERCEPT - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £16,350
first_seen: 2021-04-26
last_seen: 2025-08-12
first_seen_parent: 2021-11-15
last_seen_parent: 2024-01-10
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 26 times with a 11.1 weekly interval (288.6 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 12 times with a 6.5 weekly interval (78.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 221.9, "avg_administrations": 6}, {"drug": "RITUXIMAB", "avg_dose_mg": 220.9, "avg_administrations": 9}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ETANERCEPT - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £14,163
first_seen: 2020-09-06
last_seen: 2025-05-23
first_seen_parent: 2021-02-06
last_seen_parent: 2025-05-22
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 10 times with a 11.3 weekly interval (113.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 15 times with a 6.5 weekly interval (97.5 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 161.4, "avg_administrations": 13}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 486.1, "avg_administrations": 30}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £13,102
first_seen: 2021-04-29
last_seen: 2025-03-09
first_seen_parent: 2018-05-12
last_seen_parent: 2024-08-09
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 444.1, "avg_administrations": 16}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 16 times with a 5.3 weekly interval (84.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOFACITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOFACITINIB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £8,589
first_seen: 2020-11-11
last_seen: 2025-03-21
first_seen_parent: 2020-12-13
last_seen_parent: 2025-12-25
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOFACITINIB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 10 times with a 2.4 weekly interval (24.0 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 5 times with a 9.8 weekly interval (49.0 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 498.6, "avg_administrations": 14}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 262.9, "avg_administrations": 15}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOFACITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOFACITINIB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £11,508
first_seen: 2020-01-02
last_seen: 2025-06-25
first_seen_parent: 2020-10-07
last_seen_parent: 2025-01-16
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOFACITINIB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 15 times with a 11.0 weekly interval (165.0 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 6 times with a 6.9 weekly interval (41.4 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 182.0, "avg_administrations": 28}, {"drug": "BARICITINIB", "avg_dose_mg": 233.9, "avg_administrations": 13}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £14,363
first_seen: 2018-11-30
last_seen: 2025-08-29
first_seen_parent: 2020-11-13
last_seen_parent: 2024-01-24
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 93.8, "avg_administrations": 10}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 6 times with a 7.2 weekly interval (43.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOCILIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOCILIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £14,149
first_seen: 2021-01-22
last_seen: 2025-02-18
first_seen_parent: 2018-12-24
last_seen_parent: 2024-03-02
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 10 times with a 6.0 weekly interval (60.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 28 times with a 9.3 weekly interval (260.4 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 431.1, "avg_administrations": 10}, {"drug": "INFLIXIMAB", "avg_dose_mg": 403.7, "avg_administrations": 30}]


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £15,077
first_seen: 2020-08-24
last_seen: 2025-10-22
first_seen_parent: 2020-09-05
last_seen_parent: 2024-01-13
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 210.4, "avg_administrations": 25}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 19 times with a 6.0 weekly interval (114.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £22,670
first_seen: 2018-08-25
last_seen: 2024-11-04
first_seen_parent: 2018-08-09
last_seen_parent: 2025-05-28
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 63.3, "avg_administrations": 13}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6 times with a 9.1 weekly interval (54.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £10,326
first_seen: 2018-10-29
last_seen: 2025-08-10
first_seen_parent: 2020-04-10
last_seen_parent: 2024-08-04
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 153.2, "avg_administrations": 23}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 24 times with a 12.0 weekly interval (288.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £11,393
first_seen: 2020-10-14
last_seen: 2024-03-01
first_seen_parent: 2017-05-20
last_seen_parent: 2025-10-01
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 411.4, "avg_administrations": 12}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 18 times with a 9.3 weekly interval (167.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Atopic dermatitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £14,253
first_seen: 2020-06-09
last_seen: 2025-07-13
first_seen_parent: 2019-11-17
last_seen_parent: 2024-09-02
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 306.5, "avg_administrations": 15}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 14 times with a 11.4 weekly interval (159.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £28,515
first_seen: 2018-09-02
last_seen: 2024-06-03
first_seen_parent: 2018-07-30
last_seen_parent: 2024-04-17
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 99.5, "avg_administrations": 4}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 22 times with a 11.0 weekly interval (242.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £21,200
first_seen: 2021-01-18
last_seen: 2024-01-13
first_seen_parent: 2017-12-22
last_seen_parent: 2025-03-12
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 54.1, "avg_administrations": 22}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 5 times with a 3.0 weekly interval (15.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £9,676
first_seen: 2018-05-29
last_seen: 2025-02-24
first_seen_parent: 2019-11-21
last_seen_parent: 2024-10-30
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 137.4, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 13 times with a 7.3 weekly interval (94.9 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - USTEKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - USTEKINUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £9,801
first_seen: 2022-05-28
last_seen: 2024-01-01
first_seen_parent: 2021-04-13
last_seen_parent: 2025-12-26
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: USTEKINUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 5 times with a 6.4 weekly interval (32.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 12 times with a 10.4 weekly interval (124.8 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 77.3, "avg_administrations": 19}, {"drug": "ETANERCEPT", "avg_dose_mg": 405.1, "avg_administrations": 19}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £12,456
first_seen: 2021-10-10
last_seen: 2024-06-26
first_seen_parent: 2019-04-23
last_seen_parent: 2025-08-26
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 127.7, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 9 times with a 5.5 weekly interval (49.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - INFLIXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - INFLIXIMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £18,243
first_seen: 2021-05-03
last_seen: 2024-12-12
first_seen_parent: 2018-07-27
last_seen_parent: 2024-04-28
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 13 times with a 10.6 weekly interval (137.8 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 12 times with a 8.1 weekly interval (97.2 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 427.4, "avg_administrations": 21}, {"drug": "ADALIMUMAB", "avg_dose_mg": 406.5, "avg_administrations": 30}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £5,395
first_seen: 2021-11-29
last_seen: 2025-02-02
first_seen_parent: 2020-07-29
last_seen_parent: 2025-09-18
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 199.7, "avg_administrations": 26}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 5 times with a 3.2 weekly interval (16.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £14,691
first_seen: 2021-03-10
last_seen: 2025-12-02
first_seen_parent: 2018-08-12
last_seen_parent: 2024-09-07
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 128.1, "avg_administrations": 4}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 30 times with a 2.4 weekly interval (72.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - ADALIMUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - ADALIMUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £11,996
first_seen: 2020-05-09
last_seen: 2024-09-03
first_seen_parent: 2020-02-15
last_seen_parent: 2025-12-26
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11 times with a 6.1 weekly interval (67.1 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 4 times with a 6.0 weekly interval (24.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 148.4, "avg_administrations": 24}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 363.4, "avg_administrations": 26}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - ADALIMUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - ADALIMUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £11,353
first_seen: 2020-01-21
last_seen: 2024-08-31
first_seen_parent: 2020-09-04
last_seen_parent: 2025-04-22
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 29 times with a 3.6 weekly interval (104.4 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 11 times with a 2.9 weekly interval (31.9 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 230.8, "avg_administrations": 15}, {"drug": "USTEKINUMAB", "avg_dose_mg": 233.3, "avg_administrations": 8}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £3,501
first_seen: 2019-07-11
last_seen: 2024-10-13
first_seen_parent: 2018-02-22
last_seen_parent: 2025-11-04
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 376.1, "avg_administrations": 15}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10 times with a 8.4 weekly interval (84.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: BEVACIZUMAB
cost_pp_pa: £12,997
first_seen: 2019-05-31
last_seen: 2025-02-06
first_seen_parent: 2019-01-18
last_seen_parent: 2025-02-16
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema - AFLIBERCEPT - BEVACIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 27 times with a 7.1 weekly interval (191.7 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 6 times with a 11.5 weekly interval (69.0 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 230.3, "avg_administrations": 22}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 348.9, "avg_administrations": 13}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: ETANERCEPT
cost_pp_pa: £5,654
first_seen: 2019-10-12
last_seen: 2024-11-08
first_seen_parent: 2018-06-05
last_seen_parent: 2024-05-26
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema - AFLIBERCEPT - ETANERCEPT

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 30 times with a 2.3 weekly interval (69.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 24 times with a 2.1 weekly interval (50.4 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 51.7, "avg_administrations": 25}, {"drug": "ETANERCEPT", "avg_dose_mg": 238.4, "avg_administrations": 22}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £10,803
first_seen: 2019-05-10
last_seen: 2024-02-09
first_seen_parent: 2017-09-06
last_seen_parent: 2025-10-29
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 292.4, "avg_administrations": 6}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 17 times with a 4.7 weekly interval (79.9 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Giant cell arteritis - TOCILIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Giant cell arteritis - TOCILIZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £16,171
first_seen: 2021-05-16
last_seen: 2025-09-18
first_seen_parent: 2021-03-03
last_seen_parent: 2024-06-29
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOCILIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 4 times with a 8.5 weekly interval (34.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 5 times with a 5.2 weekly interval (26.0 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 330.2, "avg_administrations": 4}, {"drug": "SECUKINUMAB", "avg_dose_mg": 378.7, "avg_administrations": 22}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Giant cell arteritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £11,398
first_seen: 2018-03-03
last_seen: 2025-09-22
first_seen_parent: 2020-06-01
last_seen_parent: 2024-08-02
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 192.0, "avg_administrations": 30}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 29 times with a 4.4 weekly interval (127.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer - TRASTUZUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £19,011
first_seen: 2020-10-16
last_seen: 2024-11-23
first_seen_parent: 2020-07-22
last_seen_parent: 2024-02-28
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TRASTUZUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 24 times with a 11.7 weekly interval (280.8 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 29 times with a 10.0 weekly interval (290.0 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 89.2, "avg_administrations": 14}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 176.0, "avg_administrations": 30}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer - TRASTUZUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £12,450
first_seen: 2022-09-29
last_seen: 2025-07-28
first_seen_parent: 2019-04-21
last_seen_parent: 2025-03-13
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TRASTUZUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 30 times with a 7.6 weekly interval (228.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 21 times with a 7.9 weekly interval (165.9 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 441.7, "avg_administrations": 26}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 73.1, "avg_administrations": 21}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £13,571
first_seen: 2018-11-05
last_seen: 2024-07-16
first_seen_parent: 2017-08-19
last_seen_parent: 2025-11-21
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 266.7, "avg_administrations": 24}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 25 times with a 3.4 weekly interval (85.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma - IBRUTINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma - IBRUTINIB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £14,837
first_seen: 2022-03-03
last_seen: 2025-11-26
first_seen_parent: 2020-10-03
last_seen_parent: 2024-03-12
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: IBRUTINIB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 15 times with a 2.6 weekly interval (39.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 17 times with a 10.8 weekly interval (183.6 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 347.3, "avg_administrations": 10}, {"drug": "ADALIMUMAB", "avg_dose_mg": 130.9, "avg_administrations": 30}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma - IBRUTINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma - IBRUTINIB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £8,763
first_seen: 2020-05-14
last_seen: 2025-05-17
first_seen_parent: 2018-06-09
last_seen_parent: 2025-05-04
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: IBRUTINIB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 30 times with a 6.6 weekly interval (198.0 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 11 times with a 6.3 weekly interval (69.3 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 357.2, "avg_administrations": 12}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 206.6, "avg_administrations": 24}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £26,606
first_seen: 2021-06-13
last_seen: 2025-03-27
first_seen_parent: 2017-11-22
last_seen_parent: 2025-09-19
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 312.7, "avg_administrations": 29}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 6 times with a 7.3 weekly interval (43.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma - PEMBROLIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma - PEMBROLIZUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £14,069
first_seen: 2022-10-11
last_seen: 2025-05-24
first_seen_parent: 2021-01-21
last_seen_parent: 2025-01-15
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 30 times with a 7.6 weekly interval (228.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 30 times with a 3.4 weekly interval (102.0 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 175.7, "avg_administrations": 17}, {"drug": "ETANERCEPT", "avg_dose_mg": 208.0, "avg_administrations": 27}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma - PEMBROLIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma - PEMBROLIZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £6,352
first_seen: 2022-12-10
last_seen: 2025-05-27
first_seen_parent: 2020-07-23
last_seen_parent: 2025-09-14
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 8 times with a 7.2 weekly interval (57.6 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 27 times with a 10.1 weekly interval (272.7 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 367.9, "avg_administrations": 12}, {"drug": "SECUKINUMAB", "avg_dose_mg": 298.9, "avg_administrations": 22}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £21,252
first_seen: 2021-04-29
last_seen: 2024-09-25
first_seen_parent: 2017-01-08
last_seen_parent: 2024-07-22
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 213.2, "avg_administrations": 8}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 24 times with a 6.3 weekly interval (151.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma - LENALIDOMIDE
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma - LENALIDOMIDE - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £11,954
first_seen: 2022-11-12
last_seen: 2025-12-15
first_seen_parent: 2019-06-06
last_seen_parent: 2025-07-22
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: LENALIDOMIDE|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 12 times with a 2.2 weekly interval (26.4 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 16 times with a 5.2 weekly interval (83.2 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 75.6, "avg_administrations": 20}, {"drug": "NATALIZUMAB", "avg_dose_mg": 473.3, "avg_administrations": 15}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma - LENALIDOMIDE
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma - LENALIDOMIDE - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £5,498
first_seen: 2021-01-30
last_seen: 2024-07-04
first_seen_parent: 2020-06-16
last_seen_parent: 2025-03-15
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: LENALIDOMIDE|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 11 times with a 6.5 weekly interval (71.5 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 14 times with a 9.3 weekly interval (130.2 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 292.7, "avg_administrations": 13}, {"drug": "SECUKINUMAB", "avg_dose_mg": 301.3, "avg_administrations": 5}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £15,598
first_seen: 2020-10-16
last_seen: 2025-01-31
first_seen_parent: 2017-03-23
last_seen_parent: 2025-11-11
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 269.0, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 29 times with a 7.4 weekly interval (214.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £10,437
first_seen: 2018-11-15
last_seen: 2024-08-16
first_seen_parent: 2019-08-01
last_seen_parent: 2025-02-09
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 416.0, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 19 times with a 11.9 weekly interval (226.1 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - NATALIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - NATALIZUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £10,958
first_seen: 2022-06-12
last_seen: 2025-08-28
first_seen_parent: 2018-04-19
last_seen_parent: 2025-12-15
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NATALIZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 28 times with a 9.3 weekly interval (260.4 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 5 times with a 2.2 weekly interval (11.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 59.7, "avg_administrations": 5}, {"drug": "NIVOLUMAB", "avg_dose_mg": 422.3, "avg_administrations": 12}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £21,187
first_seen: 2020-03-02
last_seen: 2024-12-28
first_seen_parent: 2019-11-11
last_seen_parent: 2024-07-27
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 84.0, "avg_administrations": 13}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 21 times with a 3.5 weekly interval (73.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: BARICITINIB
cost_pp_pa: £4,703
first_seen: 2019-09-30
last_seen: 2024-10-02
first_seen_parent: 2020-11-20
last_seen_parent: 2024-02-14
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB - BARICITINIB

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 7 times with a 5.1 weekly interval (35.7 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 15 times with a 8.8 weekly interval (132.0 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 56.4, "avg_administrations": 4}, {"drug": "BARICITINIB", "avg_dose_mg": 299.6, "avg_administrations": 13}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £16,002
first_seen: 2021-02-14
last_seen: 2024-07-03
first_seen_parent: 2020-09-22
last_seen_parent: 2024-12-02
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 206.8, "avg_administrations": 23}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 28 times with a 8.6 weekly interval (240.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £14,087
first_seen: 2021-10-06
last_seen: 2024-12-01
first_seen_parent: 2018-11-18
last_seen_parent: 2024-08-25
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 191.8, "avg_administrations": 21}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 19 times with a 7.1 weekly interval (134.9 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £7,696
first_seen: 2021-06-06
last_seen: 2024-05-28
first_seen_parent: 2020-12-21
last_seen_parent: 2024-06-18
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 481.0, "avg_administrations": 19}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 27 times with a 3.0 weekly interval (81.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - ADALIMUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - ADALIMUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £2,549
first_seen: 2019-03-20
last_seen: 2025-12-12
first_seen_parent: 2021-01-22
last_seen_parent: 2025-07-12
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 17 times with a 8.9 weekly interval (151.3 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 17 times with a 6.2 weekly interval (105.4 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 354.7, "avg_administrations": 7}, {"drug": "INFLIXIMAB", "avg_dose_mg": 108.1, "avg_administrations": 24}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £5,360
first_seen: 2019-04-19
last_seen: 2025-09-16
first_seen_parent: 2019-04-25
last_seen_parent: 2024-10-02
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 369.9, "avg_administrations": 25}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6 times with a 9.2 weekly interval (55.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £17,549
first_seen: 2018-12-12
last_seen: 2025-04-19
first_seen_parent: 2019-04-06
last_seen_parent: 2024-08-12
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 258.8, "avg_administrations": 6}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 25 times with a 4.3 weekly interval (107.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - USTEKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - USTEKINUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £12,651
first_seen: 2020-07-25
last_seen: 2025-09-15
first_seen_parent: 2019-12-11
last_seen_parent: 2024-10-09
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: USTEKINUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 22 times with a 9.9 weekly interval (217.8 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 14 times with a 10.6 weekly interval (148.4 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 391.3, "avg_administrations": 18}, {"drug": "IBRUTINIB", "avg_dose_mg": 197.5, "avg_administrations": 20}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £3,962
first_seen: 2020-12-26
last_seen: 2025-05-13
first_seen_parent: 2019-12-12
last_seen_parent: 2024-01-27
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 326.9, "avg_administrations": 13}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 12 times with a 8.1 weekly interval (97.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £24,046
first_seen: 2018-05-27
last_seen: 2024-10-12
first_seen_parent: 2018-03-25
last_seen_parent: 2024-07-30
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 304.0, "avg_administrations": 8}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 19 times with a 2.2 weekly interval (41.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £14,888
first_seen: 2020-08-01
last_seen: 2024-01-21
first_seen_parent: 2019-08-09
last_seen_parent: 2024-01-13
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 25 times with a 2.5 weekly interval (62.5 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 8 times with a 8.0 weekly interval (64.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 231.7, "avg_administrations": 15}, {"drug": "RITUXIMAB", "avg_dose_mg": 433.3, "avg_administrations": 16}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £16,827
first_seen: 2019-05-17
last_seen: 2024-10-04
first_seen_parent: 2019-03-23
last_seen_parent: 2025-04-30
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 29 times with a 4.5 weekly interval (130.5 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 4 times with a 4.4 weekly interval (17.6 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 127.4, "avg_administrations": 12}, {"drug": "ADALIMUMAB", "avg_dose_mg": 261.7, "avg_administrations": 27}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £14,154
first_seen: 2019-05-13
last_seen: 2025-12-20
first_seen_parent: 2017-08-18
last_seen_parent: 2024-07-08
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 424.8, "avg_administrations": 7}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 7 times with a 4.7 weekly interval (32.9 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Renal cell carcinoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £23,704
first_seen: 2020-05-18
last_seen: 2024-09-12
first_seen_parent: 2018-07-15
last_seen_parent: 2025-03-18
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 164.8, "avg_administrations": 4}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 14 times with a 5.2 weekly interval (72.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - RITUXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - RITUXIMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £12,401
first_seen: 2019-07-05
last_seen: 2024-03-26
first_seen_parent: 2021-11-05
last_seen_parent: 2024-10-11
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 25 times with a 6.4 weekly interval (160.0 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 12 times with a 4.1 weekly interval (49.2 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 186.4, "avg_administrations": 24}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 398.7, "avg_administrations": 12}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - RITUXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - RITUXIMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £16,375
first_seen: 2019-05-03
last_seen: 2025-07-10
first_seen_parent: 2020-08-22
last_seen_parent: 2025-02-15
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 29 times with a 9.2 weekly interval (266.8 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 29 times with a 5.6 weekly interval (162.4 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 429.9, "avg_administrations": 7}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 82.5, "avg_administrations": 24}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £22,085
first_seen: 2019-10-05
last_seen: 2025-11-14
first_seen_parent: 2019-04-23
last_seen_parent: 2025-06-15
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 52.0, "avg_administrations": 29}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 21 times with a 11.1 weekly interval (233.1 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £18,825
first_seen: 2020-11-10
last_seen: 2024-10-22
first_seen_parent: 2017-01-05
last_seen_parent: 2024-05-31
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 423.9, "avg_administrations": 13}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 27 times with a 4.2 weekly interval (113.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £26,923
first_seen: 2019-03-31
last_seen: 2024-11-08
first_seen_parent: 2017-01-04
last_seen_parent: 2025-11-04
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 304.3, "avg_administrations": 20}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 27 times with a 5.5 weekly interval (148.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £24,020
first_seen: 2018-03-19
last_seen: 2024-05-12
first_seen_parent: 2019-07-15
last_seen_parent: 2025-10-20
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 174.8, "avg_administrations": 13}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 29 times with a 7.5 weekly interval (217.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £24,086
first_seen: 2020-06-08
last_seen: 2024-11-15
first_seen_parent: 2019-06-25
last_seen_parent: 2025-09-21
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 345.6, "avg_administrations": 15}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 5 times with a 8.7 weekly interval (43.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £6,202
first_seen: 2021-05-02
last_seen: 2024-05-03
first_seen_parent: 2018-03-12
last_seen_parent: 2024-02-04
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 198.0, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4 times with a 6.1 weekly interval (24.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - VEDOLIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - VEDOLIZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £6,076
first_seen: 2021-02-03
last_seen: 2024-04-26
first_seen_parent: 2019-12-10
last_seen_parent: 2025-10-28
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: VEDOLIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 27 times with a 11.4 weekly interval (307.8 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 10 times with a 4.1 weekly interval (41.0 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 93.3, "avg_administrations": 27}, {"drug": "SECUKINUMAB", "avg_dose_mg": 170.3, "avg_administrations": 14}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £13,488
first_seen: 2020-12-06
last_seen: 2024-09-28
first_seen_parent: 2020-02-09
last_seen_parent: 2025-11-16
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 213.1, "avg_administrations": 7}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 15 times with a 9.9 weekly interval (148.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £8,910
first_seen: 2019-08-31
last_seen: 2025-05-11
first_seen_parent: 2020-08-16
last_seen_parent: 2025-09-03
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 413.9, "avg_administrations": 8}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 10 times with a 6.0 weekly interval (60.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Uveitis - ADALIMUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Uveitis - ADALIMUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £4,658
first_seen: 2020-09-17
last_seen: 2024-06-14
first_seen_parent: 2019-05-16
last_seen_parent: 2025-10-03
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 24 times with a 3.6 weekly interval (86.4 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 15 times with a 10.1 weekly interval (151.5 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 312.8, "avg_administrations": 7}, {"drug": "TOFACITINIB", "avg_dose_mg": 245.2, "avg_administrations": 22}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Uveitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £18,896
first_seen: 2018-07-30
last_seen: 2024-07-25
first_seen_parent: 2017-08-29
last_seen_parent: 2024-09-18
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 177.2, "avg_administrations": 11}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10 times with a 5.7 weekly interval (57.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £20,728
first_seen: 2018-12-26
last_seen: 2024-01-22
first_seen_parent: 2019-11-08
last_seen_parent: 2024-02-14
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 427.3, "avg_administrations": 18}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 15 times with a 5.7 weekly interval (85.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - RANIBIZUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £7,149
first_seen: 2021-04-26
last_seen: 2025-09-28
first_seen_parent: 2019-01-18
last_seen_parent: 2025-05-22
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RANIBIZUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 18 times with a 11.0 weekly interval (198.0 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 7 times with a 9.7 weekly interval (67.9 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 475.4, "avg_administrations": 4}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 55.6, "avg_administrations": 4}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - RANIBIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £12,840
first_seen: 2022-02-16
last_seen: 2024-07-25
first_seen_parent: 2019-08-18
last_seen_parent: 2024-03-11
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RANIBIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 13 times with a 11.0 weekly interval (143.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 29 times with a 3.8 weekly interval (110.2 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 267.2, "avg_administrations": 10}, {"drug": "TOFACITINIB", "avg_dose_mg": 194.9, "avg_administrations": 5}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £10,958
first_seen: 2020-12-25
last_seen: 2024-06-18
first_seen_parent: 2017-12-20
last_seen_parent: 2025-03-28
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 93.6, "avg_administrations": 28}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 22 times with a 7.9 weekly interval (173.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £12,166
first_seen: 2020-08-28
last_seen: 2025-05-05
first_seen_parent: 2020-01-06
last_seen_parent: 2025-04-16
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 19 times with a 7.2 weekly interval (136.8 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 10 times with a 6.4 weekly interval (64.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 338.3, "avg_administrations": 16}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 64.9, "avg_administrations": 26}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £23,815
first_seen: 2021-06-20
last_seen: 2024-08-03
first_seen_parent: 2017-07-01
last_seen_parent: 2024-10-22
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 296.3, "avg_administrations": 22}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 4 times with a 10.5 weekly interval (42.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £3,795
first_seen: 2019-05-04
last_seen: 2024-04-26
first_seen_parent: 2019-03-19
last_seen_parent: 2025-06-22
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 227.9, "avg_administrations": 25}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 13 times with a 10.4 weekly interval (135.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Atopic dermatitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £6,362
first_seen: 2018-02-09
last_seen: 2024-01-13
first_seen_parent: 2018-12-06
last_seen_parent: 2024-10-13
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 126.5, "avg_administrations": 6}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 16 times with a 2.7 weekly interval (43.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - RITUXIMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £12,043
first_seen: 2019-02-20
last_seen: 2024-12-14
first_seen_parent: 2020-05-21
last_seen_parent: 2024-11-01
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 13 times with a 11.4 weekly interval (148.2 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 8 times with a 6.7 weekly interval (53.6 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 452.1, "avg_administrations": 9}, {"drug": "IBRUTINIB", "avg_dose_mg": 265.7, "avg_administrations": 17}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £12,025
first_seen: 2020-12-14
last_seen: 2025-12-08
first_seen_parent: 2018-02-09
last_seen_parent: 2024-03-17
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 224.2, "avg_administrations": 20}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 29 times with a 6.8 weekly interval (197.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £19,382
first_seen: 2020-09-03
last_seen: 2024-03-07
first_seen_parent: 2017-04-19
last_seen_parent: 2025-05-20
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 85.3, "avg_administrations": 30}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 28 times with a 11.6 weekly interval (324.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £23,167
first_seen: 2018-04-23
last_seen: 2024-08-20
first_seen_parent: 2020-01-09
last_seen_parent: 2024-01-10
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 430.4, "avg_administrations": 14}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 20 times with a 2.6 weekly interval (52.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £11,162
first_seen: 2018-05-24
last_seen: 2025-07-04
first_seen_parent: 2020-11-26
last_seen_parent: 2025-12-02
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 177.6, "avg_administrations": 9}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 18 times with a 9.1 weekly interval (163.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - INFLIXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - INFLIXIMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £13,309
first_seen: 2019-09-10
last_seen: 2025-07-16
first_seen_parent: 2018-07-21
last_seen_parent: 2025-11-03
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 14 times with a 6.5 weekly interval (91.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 14 times with a 5.8 weekly interval (81.2 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 187.2, "avg_administrations": 11}, {"drug": "SECUKINUMAB", "avg_dose_mg": 394.8, "avg_administrations": 22}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - INFLIXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - INFLIXIMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £7,030
first_seen: 2020-01-02
last_seen: 2024-02-10
first_seen_parent: 2021-09-14
last_seen_parent: 2024-07-23
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 28 times with a 2.3 weekly interval (64.4 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 12 times with a 10.4 weekly interval (124.8 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 167.0, "avg_administrations": 13}, {"drug": "ETANERCEPT", "avg_dose_mg": 391.6, "avg_administrations": 28}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £10,422
first_seen: 2018-05-08
last_seen: 2024-04-16
first_seen_parent: 2019-09-07
last_seen_parent: 2024-02-05
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 99.3, "avg_administrations": 7}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 10 times with a 6.4 weekly interval (64.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Diabetic macular oedema
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £11,806
first_seen: 2020-03-08
last_seen: 2025-02-19
first_seen_parent: 2017-12-31
last_seen_parent: 2024-01-10
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 418.1, "avg_administrations": 14}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 15 times with a 4.0 weekly interval (60.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £14,293
first_seen: 2021-10-19
last_seen: 2025-10-12
first_seen_parent: 2018-11-22
last_seen_parent: 2025-04-06
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOCILIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 6 times with a 2.8 weekly interval (16.8 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 19 times with a 4.6 weekly interval (87.4 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 364.6, "avg_administrations": 21}, {"drug": "TOFACITINIB", "avg_dose_mg": 99.8, "avg_administrations": 13}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £9,089
first_seen: 2021-01-14
last_seen: 2024-12-09
first_seen_parent: 2020-12-28
last_seen_parent: 2024-08-20
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 149.9, "avg_administrations": 28}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 27 times with a 11.9 weekly interval (321.3 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £18,180
first_seen: 2019-07-09
last_seen: 2024-01-27
first_seen_parent: 2020-04-08
last_seen_parent: 2024-05-02
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 270.4, "avg_administrations": 7}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 18 times with a 5.3 weekly interval (95.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Mantle cell lymphoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £5,658
first_seen: 2018-03-11
last_seen: 2024-03-11
first_seen_parent: 2019-03-29
last_seen_parent: 2025-10-02
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 413.6, "avg_administrations": 11}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 24 times with a 7.6 weekly interval (182.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £3,500
first_seen: 2019-04-05
last_seen: 2025-09-23
first_seen_parent: 2020-09-20
last_seen_parent: 2024-12-21
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 150.8, "avg_administrations": 17}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 22 times with a 10.6 weekly interval (233.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma - LENALIDOMIDE
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma - LENALIDOMIDE - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £16,650
first_seen: 2021-01-21
last_seen: 2024-05-09
first_seen_parent: 2020-06-16
last_seen_parent: 2024-03-26
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: LENALIDOMIDE|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 26 times with a 11.9 weekly interval (309.4 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 13 times with a 6.3 weekly interval (81.9 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 102.5, "avg_administrations": 8}, {"drug": "SECUKINUMAB", "avg_dose_mg": 256.0, "avg_administrations": 12}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma - LENALIDOMIDE
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma - LENALIDOMIDE - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £8,313
first_seen: 2021-05-29
last_seen: 2024-01-24
first_seen_parent: 2020-10-13
last_seen_parent: 2025-09-24
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: LENALIDOMIDE|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 11 times with a 5.7 weekly interval (62.7 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 5 times with a 2.7 weekly interval (13.5 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 303.6, "avg_administrations": 26}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 347.4, "avg_administrations": 4}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £19,926
first_seen: 2018-08-16
last_seen: 2024-11-19
first_seen_parent: 2019-04-09
last_seen_parent: 2024-12-28
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 443.4, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 9 times with a 9.9 weekly interval (89.1 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £22,350
first_seen: 2019-08-13
last_seen: 2025-06-20
first_seen_parent: 2017-11-12
last_seen_parent: 2024-09-04
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 144.5, "avg_administrations": 6}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 5 times with a 3.4 weekly interval (17.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £12,265
first_seen: 2019-07-29
last_seen: 2024-10-23
first_seen_parent: 2020-11-16
last_seen_parent: 2024-11-06
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 440.4, "avg_administrations": 6}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 10 times with a 3.7 weekly interval (37.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-Hodgkin lymphoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £5,580
first_seen: 2020-12-27
last_seen: 2024-01-30
first_seen_parent: 2018-07-06
last_seen_parent: 2025-12-04
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 360.5, "avg_administrations": 10}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 21 times with a 2.0 weekly interval (42.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £6,367
first_seen: 2019-03-12
last_seen: 2025-03-12
first_seen_parent: 2018-12-01
last_seen_parent: 2025-06-10
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 421.0, "avg_administrations": 20}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 15 times with a 4.1 weekly interval (61.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £11,550
first_seen: 2020-03-16
last_seen: 2024-01-23
first_seen_parent: 2018-12-03
last_seen_parent: 2024-09-14
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 308.3, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 30 times with a 11.4 weekly interval (342.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £22,163
first_seen: 2020-12-08
last_seen: 2025-01-05
first_seen_parent: 2018-06-18
last_seen_parent: 2025-02-27
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 272.2, "avg_administrations": 29}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 11 times with a 11.0 weekly interval (121.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - ADALIMUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £7,485
first_seen: 2019-04-15
last_seen: 2025-02-02
first_seen_parent: 2019-06-10
last_seen_parent: 2025-01-02
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 28 times with a 6.0 weekly interval (168.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 20 times with a 9.0 weekly interval (180.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 76.1, "avg_administrations": 25}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 387.3, "avg_administrations": 17}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £21,373
first_seen: 2018-10-06
last_seen: 2024-06-11
first_seen_parent: 2017-04-17
last_seen_parent: 2024-02-02
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 462.4, "avg_administrations": 26}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4 times with a 4.5 weekly interval (18.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - SECUKINUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - SECUKINUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £11,018
first_seen: 2019-08-22
last_seen: 2024-10-03
first_seen_parent: 2020-12-06
last_seen_parent: 2024-04-02
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 14 times with a 10.5 weekly interval (147.0 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 6 times with a 11.7 weekly interval (70.2 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 320.0, "avg_administrations": 6}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 178.2, "avg_administrations": 11}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - SECUKINUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - SECUKINUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £13,851
first_seen: 2020-09-22
last_seen: 2025-05-11
first_seen_parent: 2018-03-26
last_seen_parent: 2025-04-11
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 21 times with a 5.5 weekly interval (115.5 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 28 times with a 8.9 weekly interval (249.2 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 190.4, "avg_administrations": 16}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 177.6, "avg_administrations": 17}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £16,501
first_seen: 2018-05-12
last_seen: 2024-01-16
first_seen_parent: 2019-12-04
last_seen_parent: 2025-07-29
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 52.8, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 12 times with a 6.5 weekly interval (78.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £4,986
first_seen: 2020-04-12
last_seen: 2024-07-08
first_seen_parent: 2020-09-26
last_seen_parent: 2024-01-06
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 253.6, "avg_administrations": 22}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 26 times with a 8.1 weekly interval (210.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £18,755
first_seen: 2021-08-15
last_seen: 2025-09-30
first_seen_parent: 2019-08-15
last_seen_parent: 2025-03-30
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 482.2, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 4 times with a 5.6 weekly interval (22.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £15,161
first_seen: 2019-08-21
last_seen: 2025-07-18
first_seen_parent: 2019-05-20
last_seen_parent: 2024-06-20
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 302.3, "avg_administrations": 24}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 4 times with a 6.4 weekly interval (25.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Renal cell carcinoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £14,877
first_seen: 2020-05-26
last_seen: 2024-04-15
first_seen_parent: 2019-11-03
last_seen_parent: 2025-01-20
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 95.3, "avg_administrations": 27}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 7 times with a 8.5 weekly interval (59.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £9,402
first_seen: 2019-04-28
last_seen: 2024-07-15
first_seen_parent: 2020-06-16
last_seen_parent: 2025-12-19
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 4 times with a 4.7 weekly interval (18.8 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 7 times with a 2.8 weekly interval (19.6 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 336.6, "avg_administrations": 12}, {"drug": "TOFACITINIB", "avg_dose_mg": 465.0, "avg_administrations": 29}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £16,241
first_seen: 2022-05-01
last_seen: 2025-12-25
first_seen_parent: 2020-04-22
last_seen_parent: 2025-11-22
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 24 times with a 2.5 weekly interval (60.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 23 times with a 5.9 weekly interval (135.7 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 351.0, "avg_administrations": 25}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 212.2, "avg_administrations": 10}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £12,322
first_seen: 2021-10-15
last_seen: 2024-07-14
first_seen_parent: 2017-06-16
last_seen_parent: 2025-08-05
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 488.2, "avg_administrations": 26}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 28 times with a 10.7 weekly interval (299.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £14,441
first_seen: 2020-05-28
last_seen: 2024-09-19
first_seen_parent: 2017-10-04
last_seen_parent: 2025-07-04
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 114.9, "avg_administrations": 8}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 6 times with a 9.0 weekly interval (54.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £21,746
first_seen: 2019-03-19
last_seen: 2024-11-25
first_seen_parent: 2019-04-06
last_seen_parent: 2025-04-25
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 166.7, "avg_administrations": 21}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 9 times with a 7.9 weekly interval (71.1 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - INFLIXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - INFLIXIMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £18,204
first_seen: 2019-10-21
last_seen: 2024-03-19
first_seen_parent: 2021-07-27
last_seen_parent: 2025-03-02
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 8 times with a 5.5 weekly interval (44.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 21 times with a 4.6 weekly interval (96.6 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 78.0, "avg_administrations": 16}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 323.4, "avg_administrations": 30}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - INFLIXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - INFLIXIMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £16,020
first_seen: 2022-09-14
last_seen: 2025-10-30
first_seen_parent: 2018-07-18
last_seen_parent: 2025-08-03
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 13 times with a 4.2 weekly interval (54.6 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 15 times with a 2.9 weekly interval (43.5 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 250.6, "avg_administrations": 29}, {"drug": "NIVOLUMAB", "avg_dose_mg": 475.6, "avg_administrations": 20}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £5,610
first_seen: 2018-02-03
last_seen: 2025-10-19
first_seen_parent: 2018-01-25
last_seen_parent: 2025-06-27
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 126.5, "avg_administrations": 8}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 9 times with a 4.0 weekly interval (36.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £7,194
first_seen: 2021-01-30
last_seen: 2025-07-24
first_seen_parent: 2020-04-28
last_seen_parent: 2024-08-23
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 392.5, "avg_administrations": 5}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 13 times with a 2.3 weekly interval (29.9 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Uveitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £15,750
first_seen: 2019-09-01
last_seen: 2025-12-12
first_seen_parent: 2018-04-30
last_seen_parent: 2025-03-25
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 215.5, "avg_administrations": 26}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 17 times with a 5.4 weekly interval (91.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £18,611
first_seen: 2020-06-28
last_seen: 2025-10-04
first_seen_parent: 2019-01-16
last_seen_parent: 2024-02-10
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 234.9, "avg_administrations": 23}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 30 times with a 9.6 weekly interval (288.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - ETANERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - ETANERCEPT - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £12,719
first_seen: 2019-03-23
last_seen: 2024-02-11
first_seen_parent: 2020-09-09
last_seen_parent: 2025-06-09
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 24 times with a 5.9 weekly interval (141.6 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 24 times with a 6.4 weekly interval (153.6 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 298.5, "avg_administrations": 30}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 179.6, "avg_administrations": 22}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - ETANERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - ETANERCEPT - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £3,706
first_seen: 2022-10-01
last_seen: 2024-09-13
first_seen_parent: 2020-06-19
last_seen_parent: 2024-01-01
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 23 times with a 11.7 weekly interval (269.1 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 5 times with a 2.2 weekly interval (11.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 224.1, "avg_administrations": 8}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 310.9, "avg_administrations": 22}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £6,955
first_seen: 2020-08-14
last_seen: 2024-08-10
first_seen_parent: 2020-02-21
last_seen_parent: 2024-12-22
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 162.7, "avg_administrations": 29}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 11 times with a 9.7 weekly interval (106.7 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - SECUKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - SECUKINUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £8,945
first_seen: 2022-03-29
last_seen: 2025-04-09
first_seen_parent: 2019-03-23
last_seen_parent: 2025-04-26
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 18 times with a 3.5 weekly interval (63.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 23 times with a 11.5 weekly interval (264.5 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 448.2, "avg_administrations": 23}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 481.4, "avg_administrations": 13}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £4,974
first_seen: 2021-09-15
last_seen: 2024-04-24
first_seen_parent: 2019-07-24
last_seen_parent: 2024-12-01
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 75.8, "avg_administrations": 10}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 6 times with a 6.5 weekly interval (39.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Atopic dermatitis - BARICITINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Atopic dermatitis - BARICITINIB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £7,019
first_seen: 2020-03-08
last_seen: 2025-09-09
first_seen_parent: 2021-08-14
last_seen_parent: 2024-07-25
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BARICITINIB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 22 times with a 8.9 weekly interval (195.8 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 29 times with a 8.0 weekly interval (232.0 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 329.2, "avg_administrations": 10}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 134.1, "avg_administrations": 27}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Atopic dermatitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £18,301
first_seen: 2020-10-15
last_seen: 2025-10-31
first_seen_parent: 2017-03-15
last_seen_parent: 2024-05-19
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 451.7, "avg_administrations": 24}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 11 times with a 10.7 weekly interval (117.7 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - RITUXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - RITUXIMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £18,356
first_seen: 2021-09-11
last_seen: 2024-07-13
first_seen_parent: 2019-06-29
last_seen_parent: 2025-05-23
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 12 times with a 9.2 weekly interval (110.4 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 17 times with a 10.2 weekly interval (173.4 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 324.4, "avg_administrations": 13}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 413.3, "avg_administrations": 28}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £18,440
first_seen: 2021-10-29
last_seen: 2024-01-15
first_seen_parent: 2017-05-31
last_seen_parent: 2024-08-27
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 196.4, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 17 times with a 9.5 weekly interval (161.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - IBRUTINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - IBRUTINIB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £13,846
first_seen: 2020-10-06
last_seen: 2025-02-04
first_seen_parent: 2019-07-11
last_seen_parent: 2025-02-27
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: IBRUTINIB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 12 times with a 10.0 weekly interval (120.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 30 times with a 8.7 weekly interval (261.0 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 73.3, "avg_administrations": 8}, {"drug": "RITUXIMAB", "avg_dose_mg": 179.4, "avg_administrations": 10}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £18,804
first_seen: 2018-11-09
last_seen: 2024-08-05
first_seen_parent: 2018-05-18
last_seen_parent: 2024-09-24
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 239.4, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 24 times with a 10.3 weekly interval (247.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Colorectal cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £26,296
first_seen: 2020-10-27
last_seen: 2024-06-22
first_seen_parent: 2019-07-04
last_seen_parent: 2024-11-12
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 369.2, "avg_administrations": 11}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 16 times with a 10.2 weekly interval (163.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - VEDOLIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - VEDOLIZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £11,575
first_seen: 2020-09-22
last_seen: 2024-06-21
first_seen_parent: 2021-03-18
last_seen_parent: 2025-07-24
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: VEDOLIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 7 times with a 6.5 weekly interval (45.5 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 20 times with a 11.6 weekly interval (232.0 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 329.8, "avg_administrations": 8}, {"drug": "SECUKINUMAB", "avg_dose_mg": 409.3, "avg_administrations": 30}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - VEDOLIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - VEDOLIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £3,110
first_seen: 2020-08-02
last_seen: 2025-01-11
first_seen_parent: 2020-08-16
last_seen_parent: 2024-01-02
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: VEDOLIZUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 13 times with a 11.1 weekly interval (144.3 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 26 times with a 9.2 weekly interval (239.2 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 347.1, "avg_administrations": 9}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 311.7, "avg_administrations": 8}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £14,523
first_seen: 2020-12-12
last_seen: 2025-04-06
first_seen_parent: 2020-05-04
last_seen_parent: 2024-01-24
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 97.2, "avg_administrations": 16}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 15 times with a 6.7 weekly interval (100.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £15,930
first_seen: 2020-01-03
last_seen: 2025-04-07
first_seen_parent: 2019-03-09
last_seen_parent: 2025-05-28
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 435.8, "avg_administrations": 27}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 17 times with a 3.8 weekly interval (64.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £24,259
first_seen: 2018-11-27
last_seen: 2025-03-13
first_seen_parent: 2018-03-02
last_seen_parent: 2024-03-03
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 92.1, "avg_administrations": 23}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18 times with a 9.8 weekly interval (176.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - INFLIXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - INFLIXIMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £19,587
first_seen: 2022-05-20
last_seen: 2025-10-16
first_seen_parent: 2020-03-30
last_seen_parent: 2025-07-27
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 11 times with a 3.3 weekly interval (36.3 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 10 times with a 6.2 weekly interval (62.0 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 51.1, "avg_administrations": 28}, {"drug": "ETANERCEPT", "avg_dose_mg": 166.8, "avg_administrations": 8}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - INFLIXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - INFLIXIMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £18,214
first_seen: 2022-05-07
last_seen: 2024-11-10
first_seen_parent: 2018-10-02
last_seen_parent: 2024-12-07
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 11 times with a 5.8 weekly interval (63.8 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 7 times with a 4.2 weekly interval (29.4 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 354.6, "avg_administrations": 14}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 56.1, "avg_administrations": 9}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £7,779
first_seen: 2018-08-04
last_seen: 2024-06-21
first_seen_parent: 2019-11-11
last_seen_parent: 2025-02-12
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 206.1, "avg_administrations": 27}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 28 times with a 2.4 weekly interval (67.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £19,853
first_seen: 2021-11-13
last_seen: 2025-03-16
first_seen_parent: 2020-02-07
last_seen_parent: 2025-04-05
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 324.6, "avg_administrations": 29}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 12 times with a 3.7 weekly interval (44.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Giant cell arteritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £8,746
first_seen: 2019-12-30
last_seen: 2025-10-18
first_seen_parent: 2017-12-11
last_seen_parent: 2024-08-19
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 448.9, "avg_administrations": 27}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 27 times with a 8.5 weekly interval (229.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £6,629
first_seen: 2020-06-04
last_seen: 2025-01-14
first_seen_parent: 2017-05-28
last_seen_parent: 2024-12-15
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 339.5, "avg_administrations": 5}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 19 times with a 8.4 weekly interval (159.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Mantle cell lymphoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £25,545
first_seen: 2018-07-20
last_seen: 2025-02-20
first_seen_parent: 2019-02-04
last_seen_parent: 2024-10-13
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 107.9, "avg_administrations": 6}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 8 times with a 7.8 weekly interval (62.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Melanoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £5,090
first_seen: 2020-04-03
last_seen: 2024-06-07
first_seen_parent: 2020-10-01
last_seen_parent: 2024-03-28
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 326.3, "avg_administrations": 11}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 14 times with a 9.3 weekly interval (130.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £15,011
first_seen: 2020-03-03
last_seen: 2025-09-19
first_seen_parent: 2019-01-23
last_seen_parent: 2025-04-14
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 145.7, "avg_administrations": 6}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 22 times with a 8.2 weekly interval (180.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £14,490
first_seen: 2019-08-08
last_seen: 2024-12-17
first_seen_parent: 2019-11-22
last_seen_parent: 2024-12-26
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 398.3, "avg_administrations": 12}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 26 times with a 7.8 weekly interval (202.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £11,615
first_seen: 2020-02-15
last_seen: 2024-10-07
first_seen_parent: 2019-06-13
last_seen_parent: 2025-09-06
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 411.9, "avg_administrations": 12}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 18 times with a 8.2 weekly interval (147.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma - RITUXIMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £8,739
first_seen: 2019-10-03
last_seen: 2025-10-31
first_seen_parent: 2020-05-10
last_seen_parent: 2025-11-12
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 21 times with a 11.0 weekly interval (231.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 12 times with a 6.8 weekly interval (81.6 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 463.6, "avg_administrations": 27}, {"drug": "ADALIMUMAB", "avg_dose_mg": 262.7, "avg_administrations": 16}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma - RITUXIMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £8,491
first_seen: 2019-06-16
last_seen: 2024-02-19
first_seen_parent: 2020-07-14
last_seen_parent: 2025-02-06
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 25 times with a 5.5 weekly interval (137.5 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 27 times with a 9.7 weekly interval (261.9 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 493.1, "avg_administrations": 24}, {"drug": "SECUKINUMAB", "avg_dose_mg": 62.0, "avg_administrations": 8}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £7,971
first_seen: 2018-04-16
last_seen: 2024-08-27
first_seen_parent: 2018-11-16
last_seen_parent: 2024-09-22
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 360.4, "avg_administrations": 23}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 15 times with a 10.4 weekly interval (156.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £8,398
first_seen: 2018-10-06
last_seen: 2024-07-01
first_seen_parent: 2019-01-27
last_seen_parent: 2024-08-23
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 161.9, "avg_administrations": 27}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 20 times with a 11.4 weekly interval (228.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £18,687
first_seen: 2018-09-06
last_seen: 2024-12-07
first_seen_parent: 2017-05-22
last_seen_parent: 2024-05-28
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 298.9, "avg_administrations": 23}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 29 times with a 8.6 weekly interval (249.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £6,617
first_seen: 2022-02-13
last_seen: 2025-11-15
first_seen_parent: 2019-08-13
last_seen_parent: 2024-01-17
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 28 times with a 11.8 weekly interval (330.4 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 17 times with a 9.3 weekly interval (158.1 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 447.3, "avg_administrations": 13}, {"drug": "INFLIXIMAB", "avg_dose_mg": 171.9, "avg_administrations": 13}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £15,336
first_seen: 2018-04-06
last_seen: 2024-12-16
first_seen_parent: 2017-01-13
last_seen_parent: 2025-03-28
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 62.6, "avg_administrations": 22}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 11 times with a 6.2 weekly interval (68.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £18,947
first_seen: 2021-09-12
last_seen: 2024-03-22
first_seen_parent: 2021-03-02
last_seen_parent: 2024-01-25
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 19 times with a 2.2 weekly interval (41.8 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 9 times with a 5.1 weekly interval (45.9 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 268.1, "avg_administrations": 4}, {"drug": "NIVOLUMAB", "avg_dose_mg": 487.0, "avg_administrations": 24}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £6,821
first_seen: 2022-08-17
last_seen: 2025-01-13
first_seen_parent: 2018-06-16
last_seen_parent: 2025-04-18
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 23 times with a 4.7 weekly interval (108.1 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 26 times with a 5.7 weekly interval (148.2 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 367.2, "avg_administrations": 6}, {"drug": "NATALIZUMAB", "avg_dose_mg": 140.8, "avg_administrations": 9}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £19,517
first_seen: 2020-06-21
last_seen: 2024-08-02
first_seen_parent: 2017-10-31
last_seen_parent: 2025-11-22
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 235.1, "avg_administrations": 7}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 28 times with a 8.8 weekly interval (246.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - SECUKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - SECUKINUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £11,502
first_seen: 2022-07-19
last_seen: 2024-04-06
first_seen_parent: 2020-10-03
last_seen_parent: 2025-04-21
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 17 times with a 3.7 weekly interval (62.9 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 9 times with a 3.0 weekly interval (27.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 341.8, "avg_administrations": 10}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 379.1, "avg_administrations": 18}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £9,788
first_seen: 2021-06-07
last_seen: 2025-02-06
first_seen_parent: 2020-01-28
last_seen_parent: 2024-03-12
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 170.4, "avg_administrations": 17}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 20 times with a 7.2 weekly interval (144.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - USTEKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - USTEKINUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £10,290
first_seen: 2021-01-15
last_seen: 2025-11-13
first_seen_parent: 2020-11-19
last_seen_parent: 2024-03-30
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 10 times with a 2.0 weekly interval (20.0 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 12 times with a 9.6 weekly interval (115.2 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 141.5, "avg_administrations": 6}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 142.2, "avg_administrations": 28}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - USTEKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - USTEKINUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £4,771
first_seen: 2021-10-11
last_seen: 2025-05-24
first_seen_parent: 2020-01-14
last_seen_parent: 2025-12-07
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 15 times with a 6.5 weekly interval (97.5 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 26 times with a 6.3 weekly interval (163.8 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 215.3, "avg_administrations": 15}, {"drug": "NIVOLUMAB", "avg_dose_mg": 167.0, "avg_administrations": 18}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £18,502
first_seen: 2019-12-06
last_seen: 2024-12-26
first_seen_parent: 2018-05-27
last_seen_parent: 2024-02-02
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 186.8, "avg_administrations": 23}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 18 times with a 3.3 weekly interval (59.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - ETANERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - ETANERCEPT - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £12,967
first_seen: 2022-12-10
last_seen: 2025-09-17
first_seen_parent: 2018-03-04
last_seen_parent: 2024-09-01
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 17 times with a 5.2 weekly interval (88.4 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 19 times with a 5.2 weekly interval (98.8 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 408.8, "avg_administrations": 6}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 329.6, "avg_administrations": 20}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £7,306
first_seen: 2021-01-22
last_seen: 2024-12-28
first_seen_parent: 2020-07-21
last_seen_parent: 2025-10-07
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 178.6, "avg_administrations": 20}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 25 times with a 4.4 weekly interval (110.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £10,509
first_seen: 2021-08-11
last_seen: 2024-03-17
first_seen_parent: 2017-02-15
last_seen_parent: 2025-07-24
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 81.1, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 12 times with a 10.6 weekly interval (127.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £19,418
first_seen: 2020-02-15
last_seen: 2025-09-07
first_seen_parent: 2020-04-14
last_seen_parent: 2024-02-15
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 89.2, "avg_administrations": 28}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 13 times with a 10.5 weekly interval (136.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £9,267
first_seen: 2020-01-30
last_seen: 2024-12-06
first_seen_parent: 2020-03-13
last_seen_parent: 2024-04-20
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 142.1, "avg_administrations": 10}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 18 times with a 6.8 weekly interval (122.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £22,931
first_seen: 2018-12-04
last_seen: 2025-04-13
first_seen_parent: 2017-10-23
last_seen_parent: 2024-10-29
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 296.9, "avg_administrations": 14}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 28 times with a 5.5 weekly interval (154.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £6,687
first_seen: 2021-05-22
last_seen: 2024-11-18
first_seen_parent: 2017-10-15
last_seen_parent: 2025-01-01
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 277.0, "avg_administrations": 11}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6 times with a 2.3 weekly interval (13.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £24,092
first_seen: 2018-10-20
last_seen: 2025-06-13
first_seen_parent: 2019-08-02
last_seen_parent: 2024-10-26
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 101.3, "avg_administrations": 5}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 19 times with a 9.9 weekly interval (188.1 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £15,255
first_seen: 2019-07-23
last_seen: 2025-06-30
first_seen_parent: 2018-02-04
last_seen_parent: 2025-06-29
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 93.4, "avg_administrations": 13}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 8 times with a 8.8 weekly interval (70.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Uveitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £14,271
first_seen: 2021-01-08
last_seen: 2024-08-05
first_seen_parent: 2018-12-10
last_seen_parent: 2025-05-01
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 431.6, "avg_administrations": 20}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 30 times with a 5.1 weekly interval (153.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £6,671
first_seen: 2019-06-26
last_seen: 2024-07-23
first_seen_parent: 2020-03-18
last_seen_parent: 2024-04-01
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 499.5, "avg_administrations": 12}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 13 times with a 9.7 weekly interval (126.1 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £4,414
first_seen: 2018-06-29
last_seen: 2024-08-27
first_seen_parent: 2017-12-27
last_seen_parent: 2024-04-18
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 302.8, "avg_administrations": 25}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 27 times with a 6.8 weekly interval (183.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £26,900
first_seen: 2018-10-27
last_seen: 2025-09-07
first_seen_parent: 2019-09-22
last_seen_parent: 2025-01-13
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 150.4, "avg_administrations": 24}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 28 times with a 2.7 weekly interval (75.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £6,179
first_seen: 2020-12-27
last_seen: 2024-11-24
first_seen_parent: 2021-12-08
last_seen_parent: 2024-08-27
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB - PEMBROLIZUMAB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 17 times with a 8.2 weekly interval (139.4 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 15 times with a 11.9 weekly interval (178.5 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 295.0, "avg_administrations": 30}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 191.0, "avg_administrations": 15}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £8,745
first_seen: 2020-11-14
last_seen: 2025-01-11
first_seen_parent: 2017-05-17
last_seen_parent: 2025-03-15
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 380.0, "avg_administrations": 21}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 15 times with a 11.0 weekly interval (165.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Atopic dermatitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £14,850
first_seen: 2018-09-01
last_seen: 2024-12-14
first_seen_parent: 2020-10-22
last_seen_parent: 2024-06-24
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 457.0, "avg_administrations": 23}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 12 times with a 4.4 weekly interval (52.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £12,575
first_seen: 2019-05-22
last_seen: 2024-10-29
first_seen_parent: 2017-05-31
last_seen_parent: 2025-03-31
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 393.3, "avg_administrations": 30}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 23 times with a 10.9 weekly interval (250.7 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £9,191
first_seen: 2020-07-13
last_seen: 2024-01-04
first_seen_parent: 2018-05-01
last_seen_parent: 2025-02-02
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 478.7, "avg_administrations": 15}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 29 times with a 12.0 weekly interval (348.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £21,509
first_seen: 2019-05-15
last_seen: 2024-01-17
first_seen_parent: 2018-10-21
last_seen_parent: 2024-03-22
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 317.2, "avg_administrations": 8}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 21 times with a 11.7 weekly interval (245.7 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - VEDOLIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - VEDOLIZUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £16,109
first_seen: 2020-06-16
last_seen: 2024-01-21
first_seen_parent: 2018-09-02
last_seen_parent: 2024-10-26
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: VEDOLIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 9 times with a 9.7 weekly interval (87.3 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 8 times with a 6.5 weekly interval (52.0 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 432.1, "avg_administrations": 13}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 183.8, "avg_administrations": 7}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £17,155
first_seen: 2019-10-26
last_seen: 2025-04-04
first_seen_parent: 2017-04-06
last_seen_parent: 2025-12-02
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 285.9, "avg_administrations": 10}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 28 times with a 2.4 weekly interval (67.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - INFLIXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - INFLIXIMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £11,512
first_seen: 2019-05-07
last_seen: 2025-04-23
first_seen_parent: 2019-02-28
last_seen_parent: 2025-07-03
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: INFLIXIMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 11 times with a 8.3 weekly interval (91.3 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 4 times with a 11.5 weekly interval (46.0 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 146.2, "avg_administrations": 22}, {"drug": "SECUKINUMAB", "avg_dose_mg": 147.7, "avg_administrations": 19}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £10,278
first_seen: 2020-06-23
last_seen: 2025-03-19
first_seen_parent: 2018-07-05
last_seen_parent: 2025-05-20
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 150.9, "avg_administrations": 17}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 20 times with a 8.9 weekly interval (178.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Diabetic macular oedema - AFLIBERCEPT
labels: OCRELIZUMAB
cost_pp_pa: £6,065
first_seen: 2021-01-23
last_seen: 2025-02-25
first_seen_parent: 2018-05-26
last_seen_parent: 2025-01-06
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: AFLIBERCEPT|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Diabetic macular oedema - AFLIBERCEPT - OCRELIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 27 times with a 3.7 weekly interval (99.9 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 26 times with a 8.5 weekly interval (221.0 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 104.5, "avg_administrations": 7}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 471.0, "avg_administrations": 14}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Diabetic macular oedema
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £7,779
first_seen: 2021-10-19
last_seen: 2024-11-18
first_seen_parent: 2019-08-10
last_seen_parent: 2024-03-09
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 112.7, "avg_administrations": 25}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4 times with a 7.4 weekly interval (29.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Giant cell arteritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £6,216
first_seen: 2021-09-10
last_seen: 2025-10-13
first_seen_parent: 2018-02-22
last_seen_parent: 2025-03-24
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 68.2, "avg_administrations": 20}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 9 times with a 2.6 weekly interval (23.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £9,884
first_seen: 2021-01-26
last_seen: 2024-06-25
first_seen_parent: 2018-01-26
last_seen_parent: 2025-01-24
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TRASTUZUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 24 times with a 8.2 weekly interval (196.8 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 26 times with a 7.0 weekly interval (182.0 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 466.5, "avg_administrations": 25}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 176.7, "avg_administrations": 10}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £24,787
first_seen: 2021-06-13
last_seen: 2025-07-06
first_seen_parent: 2020-01-17
last_seen_parent: 2025-01-19
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 96.0, "avg_administrations": 18}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 4 times with a 7.3 weekly interval (29.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Mantle cell lymphoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £15,714
first_seen: 2019-09-14
last_seen: 2024-10-03
first_seen_parent: 2018-01-30
last_seen_parent: 2025-01-29
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 385.1, "avg_administrations": 27}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 6 times with a 6.6 weekly interval (39.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Melanoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £7,568
first_seen: 2018-06-21
last_seen: 2024-10-09
first_seen_parent: 2017-12-17
last_seen_parent: 2024-11-04
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 458.3, "avg_administrations": 16}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 9 times with a 6.7 weekly interval (60.3 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple myeloma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £12,010
first_seen: 2018-05-10
last_seen: 2024-11-18
first_seen_parent: 2017-06-17
last_seen_parent: 2024-04-05
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 487.4, "avg_administrations": 19}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 10 times with a 2.3 weekly interval (23.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £6,148
first_seen: 2019-02-10
last_seen: 2025-06-28
first_seen_parent: 2020-10-10
last_seen_parent: 2024-07-25
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 61.8, "avg_administrations": 29}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 10 times with a 10.3 weekly interval (103.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - NATALIZUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £7,119
first_seen: 2019-10-30
last_seen: 2025-01-12
first_seen_parent: 2021-01-04
last_seen_parent: 2024-09-19
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NATALIZUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 27 times with a 5.5 weekly interval (148.5 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 11 times with a 3.9 weekly interval (42.9 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 192.9, "avg_administrations": 15}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 201.4, "avg_administrations": 8}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - NATALIZUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £12,924
first_seen: 2022-10-12
last_seen: 2024-06-06
first_seen_parent: 2021-03-20
last_seen_parent: 2025-03-14
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NATALIZUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 10 times with a 3.9 weekly interval (39.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 29 times with a 6.4 weekly interval (185.6 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 254.6, "avg_administrations": 27}, {"drug": "USTEKINUMAB", "avg_dose_mg": 126.0, "avg_administrations": 30}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £19,758
first_seen: 2019-12-18
last_seen: 2024-02-09
first_seen_parent: 2017-06-08
last_seen_parent: 2024-11-28
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 389.1, "avg_administrations": 29}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 26 times with a 7.9 weekly interval (205.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-Hodgkin lymphoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £15,047
first_seen: 2019-02-22
last_seen: 2024-12-31
first_seen_parent: 2019-12-04
last_seen_parent: 2024-09-01
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 459.5, "avg_administrations": 20}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 24 times with a 9.2 weekly interval (220.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB
labels: BARICITINIB
cost_pp_pa: £7,882
first_seen: 2021-12-21
last_seen: 2025-10-15
first_seen_parent: 2020-06-28
last_seen_parent: 2024-01-06
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: PEMBROLIZUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB - BARICITINIB

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 8 times with a 2.1 weekly interval (16.8 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 30 times with a 6.0 weekly interval (180.0 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 392.9, "avg_administrations": 8}, {"drug": "BARICITINIB", "avg_dose_mg": 311.9, "avg_administrations": 23}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB
labels: INFLIXIMAB
cost_pp_pa: £11,205
first_seen: 2022-09-15
last_seen: 2025-03-13
first_seen_parent: 2020-10-13
last_seen_parent: 2024-08-27
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: PEMBROLIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB - INFLIXIMAB

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 30 times with a 4.0 weekly interval (120.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 14 times with a 9.6 weekly interval (134.4 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 293.7, "avg_administrations": 4}, {"drug": "INFLIXIMAB", "avg_dose_mg": 148.7, "avg_administrations": 19}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £20,872
first_seen: 2018-03-31
last_seen: 2024-02-23
first_seen_parent: 2017-01-02
last_seen_parent: 2024-05-20
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 266.3, "avg_administrations": 13}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 12 times with a 6.8 weekly interval (81.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £8,294
first_seen: 2018-03-15
last_seen: 2025-10-11
first_seen_parent: 2019-07-17
last_seen_parent: 2024-09-23
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 344.6, "avg_administrations": 23}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 30 times with a 6.8 weekly interval (204.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £6,168
first_seen: 2019-12-13
last_seen: 2024-03-14
first_seen_parent: 2018-09-30
last_seen_parent: 2025-08-31
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB - VEDOLIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 17 times with a 11.5 weekly interval (195.5 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 9 times with a 8.3 weekly interval (74.7 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 136.2, "avg_administrations": 22}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 190.8, "avg_administrations": 9}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £18,664
first_seen: 2020-01-04
last_seen: 2025-01-06
first_seen_parent: 2019-02-07
last_seen_parent: 2024-06-19
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 86.6, "avg_administrations": 14}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 17 times with a 9.7 weekly interval (164.9 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £3,480
first_seen: 2020-12-05
last_seen: 2024-02-04
first_seen_parent: 2020-01-27
last_seen_parent: 2024-10-27
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 104.7, "avg_administrations": 10}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 21 times with a 4.4 weekly interval (92.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,053
first_seen: 2019-12-07
last_seen: 2024-05-07
first_seen_parent: 2021-01-13
last_seen_parent: 2024-12-01
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 10 times with a 7.8 weekly interval (78.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 12 times with a 3.6 weekly interval (43.2 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 251.6, "avg_administrations": 19}, {"drug": "RITUXIMAB", "avg_dose_mg": 337.0, "avg_administrations": 22}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £7,060
first_seen: 2020-08-14
last_seen: 2025-09-24
first_seen_parent: 2019-02-18
last_seen_parent: 2024-08-20
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 10 times with a 6.0 weekly interval (60.0 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 25 times with a 6.0 weekly interval (150.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 490.9, "avg_administrations": 24}, {"drug": "BARICITINIB", "avg_dose_mg": 464.0, "avg_administrations": 15}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £5,550
first_seen: 2021-01-20
last_seen: 2025-06-17
first_seen_parent: 2020-12-17
last_seen_parent: 2025-01-16
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 68.3, "avg_administrations": 14}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 19 times with a 3.4 weekly interval (64.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £28,607
first_seen: 2021-06-18
last_seen: 2024-10-24
first_seen_parent: 2017-06-09
last_seen_parent: 2025-10-02
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 123.7, "avg_administrations": 7}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 5 times with a 6.6 weekly interval (33.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £16,491
first_seen: 2020-03-19
last_seen: 2025-10-05
first_seen_parent: 2021-07-06
last_seen_parent: 2025-03-13
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 9 times with a 8.2 weekly interval (73.8 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 12 times with a 2.1 weekly interval (25.2 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 252.4, "avg_administrations": 28}, {"drug": "INFLIXIMAB", "avg_dose_mg": 425.4, "avg_administrations": 24}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £3,755
first_seen: 2021-03-25
last_seen: 2025-02-20
first_seen_parent: 2019-01-13
last_seen_parent: 2024-03-25
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 28 times with a 8.1 weekly interval (226.8 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 6 times with a 5.9 weekly interval (35.4 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 98.2, "avg_administrations": 8}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 291.1, "avg_administrations": 17}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £22,327
first_seen: 2018-02-18
last_seen: 2025-05-29
first_seen_parent: 2018-01-08
last_seen_parent: 2024-03-07
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 408.6, "avg_administrations": 19}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 14 times with a 4.2 weekly interval (58.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £19,100
first_seen: 2021-01-28
last_seen: 2024-05-30
first_seen_parent: 2019-12-18
last_seen_parent: 2024-08-24
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 184.5, "avg_administrations": 24}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 17 times with a 7.2 weekly interval (122.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £6,327
first_seen: 2020-02-12
last_seen: 2025-09-23
first_seen_parent: 2019-05-03
last_seen_parent: 2025-08-27
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 412.5, "avg_administrations": 5}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 20 times with a 9.8 weekly interval (196.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOCILIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOCILIZUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £15,530
first_seen: 2021-01-02
last_seen: 2025-12-14
first_seen_parent: 2019-09-03
last_seen_parent: 2024-09-16
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOCILIZUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 28 times with a 3.2 weekly interval (89.6 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 9 times with a 2.9 weekly interval (26.1 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 150.1, "avg_administrations": 18}, {"drug": "NATALIZUMAB", "avg_dose_mg": 275.0, "avg_administrations": 4}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £25,185
first_seen: 2018-04-12
last_seen: 2024-01-20
first_seen_parent: 2019-04-23
last_seen_parent: 2024-03-29
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 118.9, "avg_administrations": 28}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 26 times with a 4.0 weekly interval (104.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £15,822
first_seen: 2019-10-12
last_seen: 2025-01-09
first_seen_parent: 2020-08-11
last_seen_parent: 2025-03-10
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 415.1, "avg_administrations": 13}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 5 times with a 9.4 weekly interval (47.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £8,907
first_seen: 2018-03-06
last_seen: 2025-04-29
first_seen_parent: 2020-04-04
last_seen_parent: 2024-09-06
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 69.8, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 5 times with a 8.4 weekly interval (42.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £8,349
first_seen: 2020-08-16
last_seen: 2025-06-23
first_seen_parent: 2019-07-05
last_seen_parent: 2024-08-24
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 193.0, "avg_administrations": 29}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 26 times with a 8.3 weekly interval (215.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Uveitis - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Uveitis - ADALIMUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £17,753
first_seen: 2022-12-08
last_seen: 2024-03-22
first_seen_parent: 2019-01-28
last_seen_parent: 2024-05-24
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18 times with a 7.1 weekly interval (127.8 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 5 times with a 10.4 weekly interval (52.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 315.2, "avg_administrations": 9}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 157.7, "avg_administrations": 9}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Uveitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £7,165
first_seen: 2018-12-20
last_seen: 2025-07-29
first_seen_parent: 2018-11-14
last_seen_parent: 2024-12-29
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 442.6, "avg_administrations": 16}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 26 times with a 8.6 weekly interval (223.6 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £7,763
first_seen: 2019-02-12
last_seen: 2024-04-21
first_seen_parent: 2017-05-01
last_seen_parent: 2024-06-27
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 253.0, "avg_administrations": 17}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 8 times with a 8.5 weekly interval (68.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - RANIBIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £3,831
first_seen: 2021-05-01
last_seen: 2025-04-14
first_seen_parent: 2019-04-02
last_seen_parent: 2024-02-25
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RANIBIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 17 times with a 4.6 weekly interval (78.2 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 12 times with a 5.0 weekly interval (60.0 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 162.4, "avg_administrations": 9}, {"drug": "TOFACITINIB", "avg_dose_mg": 338.5, "avg_administrations": 22}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £18,872
first_seen: 2020-02-02
last_seen: 2025-05-17
first_seen_parent: 2018-09-03
last_seen_parent: 2025-10-09
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 130.3, "avg_administrations": 24}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 23 times with a 11.7 weekly interval (269.1 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - ETANERCEPT - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £10,907
first_seen: 2019-11-29
last_seen: 2025-07-15
first_seen_parent: 2020-09-14
last_seen_parent: 2025-03-09
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 10 times with a 4.8 weekly interval (48.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 10 times with a 4.5 weekly interval (45.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 145.3, "avg_administrations": 28}, {"drug": "ADALIMUMAB", "avg_dose_mg": 157.6, "avg_administrations": 27}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £6,907
first_seen: 2020-07-24
last_seen: 2025-09-10
first_seen_parent: 2017-05-19
last_seen_parent: 2024-01-18
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 87.4, "avg_administrations": 26}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 5 times with a 2.1 weekly interval (10.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £18,822
first_seen: 2020-02-21
last_seen: 2024-01-12
first_seen_parent: 2019-09-09
last_seen_parent: 2024-03-28
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 482.6, "avg_administrations": 13}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 25 times with a 11.8 weekly interval (295.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Atopic dermatitis - BARICITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Atopic dermatitis - BARICITINIB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £9,910
first_seen: 2021-03-19
last_seen: 2025-07-15
first_seen_parent: 2021-09-07
last_seen_parent: 2025-11-03
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BARICITINIB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 18 times with a 9.1 weekly interval (163.8 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 18 times with a 9.8 weekly interval (176.4 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 265.6, "avg_administrations": 7}, {"drug": "INFLIXIMAB", "avg_dose_mg": 387.6, "avg_administrations": 17}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Atopic dermatitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £20,129
first_seen: 2018-09-01
last_seen: 2025-11-25
first_seen_parent: 2020-03-12
last_seen_parent: 2024-04-17
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 168.8, "avg_administrations": 29}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 20 times with a 8.0 weekly interval (160.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £2,976
first_seen: 2020-01-21
last_seen: 2024-09-15
first_seen_parent: 2018-05-10
last_seen_parent: 2024-08-17
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 89.0, "avg_administrations": 30}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 26 times with a 4.7 weekly interval (122.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £18,520
first_seen: 2018-10-21
last_seen: 2025-12-03
first_seen_parent: 2019-09-25
last_seen_parent: 2024-04-01
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 156.8, "avg_administrations": 14}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 30 times with a 5.3 weekly interval (159.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Colorectal cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £9,074
first_seen: 2021-03-09
last_seen: 2024-06-02
first_seen_parent: 2017-08-31
last_seen_parent: 2025-11-05
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 458.4, "avg_administrations": 29}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 5 times with a 2.6 weekly interval (13.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £24,210
first_seen: 2019-12-04
last_seen: 2024-10-26
first_seen_parent: 2018-04-04
last_seen_parent: 2024-06-15
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 75.6, "avg_administrations": 27}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 26 times with a 2.9 weekly interval (75.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £19,962
first_seen: 2019-12-13
last_seen: 2025-08-25
first_seen_parent: 2019-08-31
last_seen_parent: 2024-07-27
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 52.7, "avg_administrations": 5}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10 times with a 2.4 weekly interval (24.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £9,161
first_seen: 2021-11-13
last_seen: 2024-11-09
first_seen_parent: 2017-09-23
last_seen_parent: 2025-09-09
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 184.3, "avg_administrations": 5}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 20 times with a 5.8 weekly interval (116.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: BEVACIZUMAB
cost_pp_pa: £12,174
first_seen: 2021-07-16
last_seen: 2025-01-25
first_seen_parent: 2019-03-03
last_seen_parent: 2025-06-04
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: AFLIBERCEPT|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema - AFLIBERCEPT - BEVACIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 15 times with a 3.0 weekly interval (45.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 8 times with a 4.3 weekly interval (34.4 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 326.0, "avg_administrations": 18}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 119.1, "avg_administrations": 10}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £13,852
first_seen: 2018-09-29
last_seen: 2025-01-24
first_seen_parent: 2019-02-27
last_seen_parent: 2024-12-03
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 199.6, "avg_administrations": 23}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 30 times with a 10.9 weekly interval (327.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Giant cell arteritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £20,898
first_seen: 2019-02-15
last_seen: 2024-11-28
first_seen_parent: 2017-01-18
last_seen_parent: 2024-05-21
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 64.6, "avg_administrations": 30}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 15 times with a 9.3 weekly interval (139.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer - TRASTUZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £9,118
first_seen: 2019-09-15
last_seen: 2024-07-18
first_seen_parent: 2020-06-01
last_seen_parent: 2025-05-16
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TRASTUZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 22 times with a 10.3 weekly interval (226.6 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 4 times with a 5.4 weekly interval (21.6 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 174.5, "avg_administrations": 16}, {"drug": "RITUXIMAB", "avg_dose_mg": 283.9, "avg_administrations": 4}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer - TRASTUZUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £15,927
first_seen: 2020-08-14
last_seen: 2024-07-13
first_seen_parent: 2018-03-10
last_seen_parent: 2025-08-05
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TRASTUZUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 29 times with a 10.2 weekly interval (295.8 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 19 times with a 11.7 weekly interval (222.3 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 430.0, "avg_administrations": 9}, {"drug": "BARICITINIB", "avg_dose_mg": 173.2, "avg_administrations": 24}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £15,054
first_seen: 2019-01-19
last_seen: 2025-07-04
first_seen_parent: 2020-12-13
last_seen_parent: 2025-01-18
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 263.3, "avg_administrations": 30}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 25 times with a 6.5 weekly interval (162.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £12,537
first_seen: 2019-02-19
last_seen: 2024-07-29
first_seen_parent: 2019-04-02
last_seen_parent: 2024-07-08
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 210.9, "avg_administrations": 5}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 25 times with a 6.8 weekly interval (170.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £10,283
first_seen: 2019-06-29
last_seen: 2024-12-07
first_seen_parent: 2019-11-07
last_seen_parent: 2025-06-29
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 422.6, "avg_administrations": 25}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 14 times with a 8.5 weekly interval (119.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple myeloma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £25,350
first_seen: 2018-10-09
last_seen: 2024-05-06
first_seen_parent: 2018-05-09
last_seen_parent: 2025-02-27
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 173.0, "avg_administrations": 16}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 26 times with a 8.3 weekly interval (215.8 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £2,632
first_seen: 2021-01-06
last_seen: 2024-01-13
first_seen_parent: 2020-08-26
last_seen_parent: 2024-01-04
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 372.3, "avg_administrations": 30}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 8 times with a 4.3 weekly interval (34.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £8,133
first_seen: 2020-04-19
last_seen: 2025-11-19
first_seen_parent: 2020-06-29
last_seen_parent: 2025-05-25
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 262.1, "avg_administrations": 21}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 20 times with a 9.8 weekly interval (196.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-Hodgkin lymphoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,839
first_seen: 2019-04-18
last_seen: 2024-07-07
first_seen_parent: 2020-10-29
last_seen_parent: 2024-02-08
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 275.4, "avg_administrations": 10}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 9 times with a 4.1 weekly interval (36.9 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £19,753
first_seen: 2021-02-26
last_seen: 2024-04-30
first_seen_parent: 2018-07-11
last_seen_parent: 2024-06-05
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 412.1, "avg_administrations": 16}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 13 times with a 11.7 weekly interval (152.1 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: ADALIMUMAB
cost_pp_pa: £16,656
first_seen: 2020-05-04
last_seen: 2024-04-06
first_seen_parent: 2018-03-23
last_seen_parent: 2024-04-28
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB - ADALIMUMAB

average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 24 times with a 10.3 weekly interval (247.2 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 26 times with a 8.4 weekly interval (218.4 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 76.9, "avg_administrations": 20}, {"drug": "ADALIMUMAB", "avg_dose_mg": 236.7, "avg_administrations": 27}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: LENALIDOMIDE
cost_pp_pa: £17,332
first_seen: 2022-03-28
last_seen: 2025-02-21
first_seen_parent: 2018-12-15
last_seen_parent: 2024-10-08
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB - LENALIDOMIDE

average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 16 times with a 10.8 weekly interval (172.8 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 29 times with a 4.6 weekly interval (133.4 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 447.1, "avg_administrations": 13}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 400.6, "avg_administrations": 21}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £14,356
first_seen: 2019-12-11
last_seen: 2025-04-13
first_seen_parent: 2017-08-26
last_seen_parent: 2024-07-16
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 83.3, "avg_administrations": 19}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 6 times with a 7.2 weekly interval (43.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: ETANERCEPT
cost_pp_pa: £9,636
first_seen: 2019-12-27
last_seen: 2024-11-09
first_seen_parent: 2021-11-13
last_seen_parent: 2025-09-24
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - BEVACIZUMAB - ETANERCEPT

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 28 times with a 10.3 weekly interval (288.4 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 5 times with a 8.5 weekly interval (42.5 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 369.7, "avg_administrations": 6}, {"drug": "ETANERCEPT", "avg_dose_mg": 74.4, "avg_administrations": 27}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £7,213
first_seen: 2018-10-29
last_seen: 2024-06-17
first_seen_parent: 2017-07-30
last_seen_parent: 2024-03-14
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 353.4, "avg_administrations": 28}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 27 times with a 3.1 weekly interval (83.7 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £10,361
first_seen: 2020-11-14
last_seen: 2024-10-08
first_seen_parent: 2017-07-15
last_seen_parent: 2025-11-22
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 333.8, "avg_administrations": 17}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 30 times with a 10.5 weekly interval (315.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £15,925
first_seen: 2019-04-21
last_seen: 2025-04-21
first_seen_parent: 2019-01-08
last_seen_parent: 2025-11-10
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 249.4, "avg_administrations": 25}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 9 times with a 11.0 weekly interval (99.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £8,592
first_seen: 2018-01-26
last_seen: 2024-06-18
first_seen_parent: 2019-10-04
last_seen_parent: 2025-12-01
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 485.0, "avg_administrations": 6}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 13 times with a 10.5 weekly interval (136.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - ETANERCEPT - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £7,267
first_seen: 2022-01-21
last_seen: 2025-11-11
first_seen_parent: 2019-03-22
last_seen_parent: 2024-08-16
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 30 times with a 4.7 weekly interval (141.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 26 times with a 3.0 weekly interval (78.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 480.3, "avg_administrations": 19}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 402.1, "avg_administrations": 21}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - ETANERCEPT - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £8,249
first_seen: 2019-10-16
last_seen: 2024-10-11
first_seen_parent: 2020-10-19
last_seen_parent: 2024-03-19
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 9 times with a 6.3 weekly interval (56.7 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 28 times with a 7.9 weekly interval (221.2 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 187.5, "avg_administrations": 29}, {"drug": "RITUXIMAB", "avg_dose_mg": 468.2, "avg_administrations": 26}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £15,407
first_seen: 2018-12-31
last_seen: 2025-06-17
first_seen_parent: 2017-06-19
last_seen_parent: 2025-06-22
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 234.8, "avg_administrations": 24}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 27 times with a 8.5 weekly interval (229.5 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £8,330
first_seen: 2021-10-01
last_seen: 2024-05-09
first_seen_parent: 2019-03-26
last_seen_parent: 2025-03-05
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 289.3, "avg_administrations": 5}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 22 times with a 11.0 weekly interval (242.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma - NIVOLUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma - NIVOLUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £7,361
first_seen: 2019-10-06
last_seen: 2024-02-16
first_seen_parent: 2018-12-31
last_seen_parent: 2025-12-02
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 10 times with a 10.3 weekly interval (103.0 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 7 times with a 11.2 weekly interval (78.4 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 181.8, "avg_administrations": 30}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 179.3, "avg_administrations": 5}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £18,532
first_seen: 2020-03-26
last_seen: 2025-09-14
first_seen_parent: 2019-03-29
last_seen_parent: 2024-03-31
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 445.5, "avg_administrations": 12}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 30 times with a 11.2 weekly interval (336.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £5,716
first_seen: 2018-07-21
last_seen: 2025-08-12
first_seen_parent: 2017-03-29
last_seen_parent: 2025-11-29
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 401.6, "avg_administrations": 12}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 20 times with a 3.2 weekly interval (64.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £21,245
first_seen: 2018-09-10
last_seen: 2024-06-26
first_seen_parent: 2017-07-26
last_seen_parent: 2024-08-04
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 219.3, "avg_administrations": 16}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 24 times with a 8.8 weekly interval (211.2 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £6,175
first_seen: 2020-02-05
last_seen: 2024-02-20
first_seen_parent: 2019-07-22
last_seen_parent: 2024-10-18
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 73.9, "avg_administrations": 10}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 17 times with a 4.9 weekly interval (83.3 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £12,764
first_seen: 2018-08-29
last_seen: 2025-09-19
first_seen_parent: 2018-11-01
last_seen_parent: 2024-06-10
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 106.0, "avg_administrations": 12}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 17 times with a 9.7 weekly interval (164.9 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £17,052
first_seen: 2019-01-08
last_seen: 2024-01-19
first_seen_parent: 2018-06-08
last_seen_parent: 2024-06-16
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 7 times with a 5.6 weekly interval (39.2 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 23 times with a 10.3 weekly interval (236.9 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 149.5, "avg_administrations": 9}, {"drug": "ETANERCEPT", "avg_dose_mg": 354.0, "avg_administrations": 18}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £23,234
first_seen: 2021-06-06
last_seen: 2024-07-06
first_seen_parent: 2017-11-05
last_seen_parent: 2024-12-30
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 52.8, "avg_administrations": 6}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 21 times with a 10.0 weekly interval (210.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - TOFACITINIB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £14,511
first_seen: 2021-03-07
last_seen: 2025-04-16
first_seen_parent: 2019-10-09
last_seen_parent: 2024-01-09
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOFACITINIB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 13 times with a 8.1 weekly interval (105.3 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 6 times with a 9.8 weekly interval (58.8 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 363.8, "avg_administrations": 22}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 281.1, "avg_administrations": 15}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £3,447
first_seen: 2021-06-06
last_seen: 2024-06-20
first_seen_parent: 2018-01-02
last_seen_parent: 2025-05-27
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 381.7, "avg_administrations": 15}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 15 times with a 11.2 weekly interval (168.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis - ADALIMUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis - ADALIMUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £3,333
first_seen: 2022-02-25
last_seen: 2025-11-11
first_seen_parent: 2019-05-30
last_seen_parent: 2024-11-12
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 23 times with a 11.6 weekly interval (266.8 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 14 times with a 9.4 weekly interval (131.6 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 139.7, "avg_administrations": 23}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 256.0, "avg_administrations": 9}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis - ADALIMUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis - ADALIMUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £10,033
first_seen: 2021-05-10
last_seen: 2024-05-25
first_seen_parent: 2019-12-05
last_seen_parent: 2025-06-26
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 21 times with a 8.2 weekly interval (172.2 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 16 times with a 8.8 weekly interval (140.8 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 293.3, "avg_administrations": 12}, {"drug": "SECUKINUMAB", "avg_dose_mg": 496.1, "avg_administrations": 17}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £6,925
first_seen: 2019-12-19
last_seen: 2025-09-26
first_seen_parent: 2019-08-26
last_seen_parent: 2024-04-08
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 202.4, "avg_administrations": 9}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 24 times with a 2.5 weekly interval (60.0 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £6,204
first_seen: 2020-11-29
last_seen: 2025-12-24
first_seen_parent: 2018-05-17
last_seen_parent: 2024-12-02
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 326.4, "avg_administrations": 16}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4 times with a 6.6 weekly interval (26.4 weeks total treatment length)


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £3,792
first_seen: 2020-11-06
last_seen: 2024-03-23
first_seen_parent: 2019-10-16
last_seen_parent: 2024-12-09
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RANIBIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 17 times with a 4.8 weekly interval (81.6 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 18 times with a 3.4 weekly interval (61.2 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 131.1, "avg_administrations": 5}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 484.5, "avg_administrations": 30}]


date_filter_id: 2yr_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £17,716
first_seen: 2018-06-22
last_seen: 2025-07-06
first_seen_parent: 2020-10-18
last_seen_parent: 2024-07-22
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 283.1, "avg_administrations": 17}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 13 times with a 11.7 weekly interval (152.1 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £15,000
first_seen: 2019-05-23
last_seen: 2024-11-07
first_seen_parent: 2020-12-18
last_seen_parent: 2025-08-03
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 183.2, "avg_administrations": 28}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 20 times with a 8.3 weekly interval (166.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £13,762
first_seen: 2020-09-16
last_seen: 2025-11-15
first_seen_parent: 2018-06-24
last_seen_parent: 2024-07-20
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 158.4, "avg_administrations": 25}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 9 times with a 11.5 weekly interval (103.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £13,448
first_seen: 2020-07-24
last_seen: 2025-08-30
first_seen_parent: 2020-10-30
last_seen_parent: 2024-08-26
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 79.7, "avg_administrations": 24}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 17 times with a 2.2 weekly interval (37.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £18,474
first_seen: 2019-08-24
last_seen: 2025-05-24
first_seen_parent: 2020-11-06
last_seen_parent: 2025-01-11
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 453.4, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 9 times with a 4.6 weekly interval (41.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £17,975
first_seen: 2019-03-09
last_seen: 2024-09-09
first_seen_parent: 2019-06-03
last_seen_parent: 2024-01-23
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 79.2, "avg_administrations": 23}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4 times with a 8.4 weekly interval (33.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - TOFACITINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - TOFACITINIB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £14,019
first_seen: 2019-11-16
last_seen: 2024-11-22
first_seen_parent: 2019-02-03
last_seen_parent: 2025-02-01
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 30 times with a 3.3 weekly interval (99.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 29 times with a 9.5 weekly interval (275.5 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 263.6, "avg_administrations": 8}, {"drug": "NATALIZUMAB", "avg_dose_mg": 140.6, "avg_administrations": 21}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £6,828
first_seen: 2020-02-11
last_seen: 2024-02-16
first_seen_parent: 2018-03-30
last_seen_parent: 2024-03-01
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 499.5, "avg_administrations": 15}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 30 times with a 8.3 weekly interval (249.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £19,744
first_seen: 2018-05-20
last_seen: 2025-10-15
first_seen_parent: 2020-03-11
last_seen_parent: 2025-06-25
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 133.6, "avg_administrations": 29}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 24 times with a 2.9 weekly interval (69.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £14,630
first_seen: 2018-06-26
last_seen: 2025-07-21
first_seen_parent: 2017-06-30
last_seen_parent: 2025-04-22
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 428.2, "avg_administrations": 5}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 25 times with a 10.3 weekly interval (257.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - LENALIDOMIDE - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £14,047
first_seen: 2021-10-17
last_seen: 2024-08-27
first_seen_parent: 2020-10-08
last_seen_parent: 2024-10-05
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 15 times with a 7.0 weekly interval (105.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 24 times with a 2.9 weekly interval (69.6 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 171.6, "avg_administrations": 10}, {"drug": "NIVOLUMAB", "avg_dose_mg": 294.8, "avg_administrations": 18}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - LENALIDOMIDE - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £4,644
first_seen: 2022-06-19
last_seen: 2025-06-14
first_seen_parent: 2021-05-15
last_seen_parent: 2025-10-21
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 7 times with a 7.1 weekly interval (49.7 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 10 times with a 11.9 weekly interval (119.0 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 330.8, "avg_administrations": 11}, {"drug": "INFLIXIMAB", "avg_dose_mg": 229.7, "avg_administrations": 17}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £12,329
first_seen: 2018-03-14
last_seen: 2024-03-31
first_seen_parent: 2020-08-06
last_seen_parent: 2025-04-23
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 251.7, "avg_administrations": 26}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 13 times with a 4.4 weekly interval (57.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - OCRELIZUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £3,308
first_seen: 2020-01-11
last_seen: 2024-06-28
first_seen_parent: 2020-02-26
last_seen_parent: 2025-12-28
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 10 times with a 10.5 weekly interval (105.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 27 times with a 9.5 weekly interval (256.5 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 480.2, "avg_administrations": 8}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 236.6, "avg_administrations": 17}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - OCRELIZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £19,727
first_seen: 2020-09-12
last_seen: 2025-03-05
first_seen_parent: 2021-09-25
last_seen_parent: 2024-12-22
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 19 times with a 11.1 weekly interval (210.9 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 9 times with a 8.6 weekly interval (77.4 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 65.1, "avg_administrations": 21}, {"drug": "SECUKINUMAB", "avg_dose_mg": 313.8, "avg_administrations": 13}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £14,425
first_seen: 2018-07-27
last_seen: 2025-09-24
first_seen_parent: 2017-10-12
last_seen_parent: 2025-05-05
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 387.7, "avg_administrations": 25}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 21 times with a 7.8 weekly interval (163.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - NATALIZUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £2,958
first_seen: 2021-04-22
last_seen: 2025-01-10
first_seen_parent: 2019-05-01
last_seen_parent: 2024-10-15
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 20 times with a 8.0 weekly interval (160.0 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 19 times with a 4.3 weekly interval (81.7 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 432.1, "avg_administrations": 14}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 227.6, "avg_administrations": 12}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - NATALIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £3,833
first_seen: 2021-08-10
last_seen: 2024-01-16
first_seen_parent: 2021-05-22
last_seen_parent: 2025-10-08
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 26 times with a 10.6 weekly interval (275.6 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 22 times with a 9.1 weekly interval (200.2 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 110.2, "avg_administrations": 19}, {"drug": "INFLIXIMAB", "avg_dose_mg": 448.3, "avg_administrations": 5}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £21,638
first_seen: 2020-02-20
last_seen: 2024-06-11
first_seen_parent: 2017-01-30
last_seen_parent: 2024-05-19
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 183.3, "avg_administrations": 25}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 5 times with a 7.6 weekly interval (38.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £25,913
first_seen: 2021-06-28
last_seen: 2024-10-23
first_seen_parent: 2018-05-24
last_seen_parent: 2025-11-28
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 326.8, "avg_administrations": 19}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 16 times with a 2.7 weekly interval (43.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £18,082
first_seen: 2019-04-13
last_seen: 2024-06-04
first_seen_parent: 2019-03-11
last_seen_parent: 2025-10-17
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 261.5, "avg_administrations": 13}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 17 times with a 7.9 weekly interval (134.3 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £17,017
first_seen: 2021-04-13
last_seen: 2024-07-17
first_seen_parent: 2018-08-22
last_seen_parent: 2024-10-02
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 487.5, "avg_administrations": 24}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 14 times with a 9.7 weekly interval (135.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £21,875
first_seen: 2019-03-13
last_seen: 2024-10-22
first_seen_parent: 2019-03-25
last_seen_parent: 2024-06-17
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 463.6, "avg_administrations": 22}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 7 times with a 11.8 weekly interval (82.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - ADALIMUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - ADALIMUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £4,588
first_seen: 2019-06-26
last_seen: 2025-07-31
first_seen_parent: 2020-04-13
last_seen_parent: 2024-04-17
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12 times with a 9.8 weekly interval (117.6 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 25 times with a 4.0 weekly interval (100.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 157.0, "avg_administrations": 29}, {"drug": "SECUKINUMAB", "avg_dose_mg": 396.0, "avg_administrations": 8}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £18,609
first_seen: 2019-10-01
last_seen: 2024-04-15
first_seen_parent: 2020-09-12
last_seen_parent: 2025-01-31
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 197.6, "avg_administrations": 4}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14 times with a 11.1 weekly interval (155.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £20,042
first_seen: 2020-08-10
last_seen: 2025-08-16
first_seen_parent: 2017-06-03
last_seen_parent: 2024-10-05
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 240.1, "avg_administrations": 18}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 17 times with a 11.3 weekly interval (192.1 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £13,063
first_seen: 2020-07-04
last_seen: 2025-06-09
first_seen_parent: 2019-07-19
last_seen_parent: 2024-01-22
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 227.1, "avg_administrations": 22}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 25 times with a 10.5 weekly interval (262.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £15,878
first_seen: 2019-07-01
last_seen: 2025-08-20
first_seen_parent: 2018-10-03
last_seen_parent: 2024-09-13
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 468.9, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 18 times with a 6.0 weekly interval (108.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ADALIMUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £13,695
first_seen: 2022-01-02
last_seen: 2025-02-06
first_seen_parent: 2021-09-22
last_seen_parent: 2024-08-28
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10 times with a 7.1 weekly interval (71.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 11 times with a 6.5 weekly interval (71.5 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 116.4, "avg_administrations": 5}, {"drug": "USTEKINUMAB", "avg_dose_mg": 125.6, "avg_administrations": 18}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ADALIMUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £19,355
first_seen: 2021-09-27
last_seen: 2025-05-09
first_seen_parent: 2020-11-22
last_seen_parent: 2024-04-19
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 28 times with a 11.5 weekly interval (322.0 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 6 times with a 10.5 weekly interval (63.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 341.7, "avg_administrations": 8}, {"drug": "IBRUTINIB", "avg_dose_mg": 452.6, "avg_administrations": 13}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £8,159
first_seen: 2021-10-08
last_seen: 2024-06-09
first_seen_parent: 2018-11-17
last_seen_parent: 2025-02-03
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 293.0, "avg_administrations": 7}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12 times with a 6.2 weekly interval (74.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £12,460
first_seen: 2021-11-27
last_seen: 2024-05-11
first_seen_parent: 2020-03-22
last_seen_parent: 2025-02-09
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 430.8, "avg_administrations": 21}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 9 times with a 11.1 weekly interval (99.9 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £11,172
first_seen: 2020-02-20
last_seen: 2024-11-09
first_seen_parent: 2018-01-31
last_seen_parent: 2024-07-16
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 135.5, "avg_administrations": 27}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 24 times with a 9.7 weekly interval (232.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £12,049
first_seen: 2019-02-14
last_seen: 2025-05-16
first_seen_parent: 2019-07-28
last_seen_parent: 2024-09-20
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 365.8, "avg_administrations": 29}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 4 times with a 5.7 weekly interval (22.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £17,041
first_seen: 2021-01-25
last_seen: 2025-02-02
first_seen_parent: 2017-11-30
last_seen_parent: 2025-12-05
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 90.9, "avg_administrations": 17}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 6 times with a 2.0 weekly interval (12.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £22,080
first_seen: 2019-11-30
last_seen: 2025-08-26
first_seen_parent: 2017-10-07
last_seen_parent: 2025-11-10
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 66.2, "avg_administrations": 20}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 17 times with a 6.3 weekly interval (107.1 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £22,864
first_seen: 2019-11-28
last_seen: 2024-08-09
first_seen_parent: 2019-10-22
last_seen_parent: 2025-06-20
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 444.8, "avg_administrations": 4}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 19 times with a 9.3 weekly interval (176.7 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £17,967
first_seen: 2022-10-10
last_seen: 2025-05-23
first_seen_parent: 2018-07-17
last_seen_parent: 2024-05-22
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 17 times with a 3.6 weekly interval (61.2 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 16 times with a 3.0 weekly interval (48.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 272.6, "avg_administrations": 9}, {"drug": "NIVOLUMAB", "avg_dose_mg": 239.3, "avg_administrations": 14}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £13,510
first_seen: 2020-07-16
last_seen: 2025-10-25
first_seen_parent: 2018-04-24
last_seen_parent: 2024-02-20
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 13 times with a 5.6 weekly interval (72.8 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 14 times with a 9.3 weekly interval (130.2 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 274.4, "avg_administrations": 22}, {"drug": "NATALIZUMAB", "avg_dose_mg": 401.5, "avg_administrations": 25}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £10,222
first_seen: 2021-11-26
last_seen: 2025-04-21
first_seen_parent: 2020-08-09
last_seen_parent: 2024-02-24
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 57.4, "avg_administrations": 21}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 23 times with a 7.9 weekly interval (181.7 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - IBRUTINIB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £10,903
first_seen: 2020-06-26
last_seen: 2025-09-21
first_seen_parent: 2019-06-09
last_seen_parent: 2024-11-12
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 19 times with a 9.3 weekly interval (176.7 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 18 times with a 6.0 weekly interval (108.0 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 164.9, "avg_administrations": 5}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 469.9, "avg_administrations": 29}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £13,954
first_seen: 2019-04-04
last_seen: 2025-06-28
first_seen_parent: 2018-01-14
last_seen_parent: 2025-12-27
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 297.3, "avg_administrations": 24}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 10 times with a 6.6 weekly interval (66.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £14,054
first_seen: 2019-12-05
last_seen: 2024-10-01
first_seen_parent: 2018-08-25
last_seen_parent: 2025-04-12
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 29 times with a 2.5 weekly interval (72.5 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 5 times with a 4.7 weekly interval (23.5 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 51.1, "avg_administrations": 10}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 363.6, "avg_administrations": 9}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £12,565
first_seen: 2019-06-30
last_seen: 2024-07-22
first_seen_parent: 2020-04-23
last_seen_parent: 2025-11-15
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 28 times with a 9.6 weekly interval (268.8 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 12 times with a 3.7 weekly interval (44.4 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 85.6, "avg_administrations": 23}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 57.3, "avg_administrations": 19}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £18,947
first_seen: 2019-01-23
last_seen: 2024-03-14
first_seen_parent: 2017-02-10
last_seen_parent: 2025-04-03
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 61.1, "avg_administrations": 14}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 12 times with a 10.0 weekly interval (120.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - OCRELIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £15,374
first_seen: 2022-08-17
last_seen: 2024-04-16
first_seen_parent: 2020-06-27
last_seen_parent: 2024-12-11
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 22 times with a 4.2 weekly interval (92.4 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 27 times with a 9.6 weekly interval (259.2 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 415.5, "avg_administrations": 25}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 141.8, "avg_administrations": 7}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £12,627
first_seen: 2021-09-24
last_seen: 2025-12-27
first_seen_parent: 2018-01-11
last_seen_parent: 2024-08-21
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 158.8, "avg_administrations": 29}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 6 times with a 7.9 weekly interval (47.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £15,226
first_seen: 2018-01-10
last_seen: 2024-07-31
first_seen_parent: 2019-11-27
last_seen_parent: 2025-09-28
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 241.0, "avg_administrations": 29}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 25 times with a 9.6 weekly interval (240.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - BEVACIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - BEVACIZUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £16,503
first_seen: 2021-12-20
last_seen: 2024-08-02
first_seen_parent: 2019-02-27
last_seen_parent: 2024-08-11
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 26 times with a 5.8 weekly interval (150.8 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 12 times with a 5.4 weekly interval (64.8 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 142.9, "avg_administrations": 15}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 54.0, "avg_administrations": 24}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £5,698
first_seen: 2020-03-02
last_seen: 2024-01-17
first_seen_parent: 2020-10-05
last_seen_parent: 2025-06-01
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 271.0, "avg_administrations": 5}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 5 times with a 9.3 weekly interval (46.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £8,492
first_seen: 2020-03-12
last_seen: 2025-11-21
first_seen_parent: 2018-11-24
last_seen_parent: 2024-07-11
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 480.0, "avg_administrations": 23}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 8 times with a 3.8 weekly interval (30.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £21,884
first_seen: 2019-07-18
last_seen: 2024-05-30
first_seen_parent: 2020-07-23
last_seen_parent: 2025-04-01
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 308.0, "avg_administrations": 28}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4 times with a 3.8 weekly interval (15.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £16,552
first_seen: 2019-11-17
last_seen: 2025-10-01
first_seen_parent: 2020-11-27
last_seen_parent: 2025-05-16
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 300.6, "avg_administrations": 30}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 6 times with a 6.6 weekly interval (39.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £19,564
first_seen: 2020-08-26
last_seen: 2025-08-25
first_seen_parent: 2018-04-27
last_seen_parent: 2024-12-20
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 87.3, "avg_administrations": 19}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 9 times with a 4.7 weekly interval (42.3 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £8,043
first_seen: 2018-05-15
last_seen: 2025-10-10
first_seen_parent: 2020-01-22
last_seen_parent: 2025-05-13
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 138.1, "avg_administrations": 20}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 16 times with a 10.3 weekly interval (164.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - ADALIMUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £16,474
first_seen: 2021-12-08
last_seen: 2025-02-14
first_seen_parent: 2020-07-26
last_seen_parent: 2024-06-08
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 29 times with a 10.5 weekly interval (304.5 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 18 times with a 2.1 weekly interval (37.8 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 315.7, "avg_administrations": 25}, {"drug": "INFLIXIMAB", "avg_dose_mg": 423.1, "avg_administrations": 20}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £26,515
first_seen: 2019-01-01
last_seen: 2025-07-27
first_seen_parent: 2017-11-06
last_seen_parent: 2024-10-19
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 180.4, "avg_administrations": 27}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 15 times with a 10.9 weekly interval (163.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £19,293
first_seen: 2020-05-02
last_seen: 2025-08-04
first_seen_parent: 2019-08-30
last_seen_parent: 2024-09-16
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 268.0, "avg_administrations": 19}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 29 times with a 6.1 weekly interval (176.9 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ADALIMUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £18,092
first_seen: 2019-04-26
last_seen: 2024-07-24
first_seen_parent: 2018-08-04
last_seen_parent: 2024-09-11
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 19 times with a 7.0 weekly interval (133.0 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 24 times with a 11.8 weekly interval (283.2 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 432.2, "avg_administrations": 23}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 60.3, "avg_administrations": 13}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ADALIMUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £10,403
first_seen: 2019-03-10
last_seen: 2024-07-07
first_seen_parent: 2020-08-16
last_seen_parent: 2025-04-06
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4 times with a 8.5 weekly interval (34.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 17 times with a 8.8 weekly interval (149.6 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 185.1, "avg_administrations": 13}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 220.6, "avg_administrations": 14}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £13,016
first_seen: 2021-05-12
last_seen: 2024-05-19
first_seen_parent: 2018-01-07
last_seen_parent: 2025-04-24
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 376.0, "avg_administrations": 17}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11 times with a 2.7 weekly interval (29.7 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £6,808
first_seen: 2018-03-26
last_seen: 2025-02-14
first_seen_parent: 2020-04-13
last_seen_parent: 2025-08-24
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 96.3, "avg_administrations": 24}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 26 times with a 7.9 weekly interval (205.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £5,596
first_seen: 2018-10-11
last_seen: 2025-12-14
first_seen_parent: 2018-12-10
last_seen_parent: 2024-02-14
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 62.4, "avg_administrations": 13}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 8 times with a 3.9 weekly interval (31.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - USTEKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - USTEKINUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £6,596
first_seen: 2022-12-23
last_seen: 2024-03-10
first_seen_parent: 2018-10-10
last_seen_parent: 2024-06-02
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 28 times with a 4.0 weekly interval (112.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 8 times with a 4.2 weekly interval (33.6 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 320.1, "avg_administrations": 5}, {"drug": "TOFACITINIB", "avg_dose_mg": 497.6, "avg_administrations": 6}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - USTEKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - USTEKINUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £16,737
first_seen: 2020-03-18
last_seen: 2024-02-26
first_seen_parent: 2021-05-11
last_seen_parent: 2024-02-23
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 27 times with a 2.5 weekly interval (67.5 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 10 times with a 3.4 weekly interval (34.0 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 279.7, "avg_administrations": 22}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 258.2, "avg_administrations": 27}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £12,894
first_seen: 2018-05-10
last_seen: 2025-07-11
first_seen_parent: 2019-04-10
last_seen_parent: 2025-10-25
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 451.0, "avg_administrations": 24}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 20 times with a 8.1 weekly interval (162.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - SECUKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - SECUKINUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £7,974
first_seen: 2022-11-28
last_seen: 2025-01-12
first_seen_parent: 2020-05-14
last_seen_parent: 2025-10-26
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 16 times with a 8.9 weekly interval (142.4 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 5 times with a 5.9 weekly interval (29.5 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 132.3, "avg_administrations": 26}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 114.8, "avg_administrations": 26}]


